<!DOCTYPE html>
<html>
<style>
    table {
        width: 100%;
        height: 50%;
    }
    
    thead,
    tbody,
    tr,
    td,
    th {
        display: block;
    }
    
    tr:after {
        content: ' ';
        display: block;
        visibility: hidden;
        clear: both;
    }
    
    thead th {
        height: 80px;
        /*text-align: left;*/
    }
    
    tbody {
        height: 800px;
        overflow-y: auto;
        overflow-x: auto;
    }
    
    thead {
        /* fallback */
    }
    
    tbody td,
    thead th {
        width: 10%;
        float: left;
    }
</style>

<body>
    <% include templates/header.ejs%>
        <div class="container">
            <p>Metabric</p>
        </div>

        <div class="container">

            <ul class="nav nav-tabs">
                <li class="active"><a data-toggle="tab" href="#part1">Part 1</a></li>
                <li><a data-toggle="tab" href="#part2">Part 2</a></li>
                <li><a data-toggle="tab" href="#part3">Part 3</a></li>
                <li><a data-toggle="tab" href="#part4">Part 4</a></li>
            </ul>

            <div class="tab-content">
                <div id="part1" class="tab-pane fade in active">
                    <p></p>
                </div>
                <div id="part2" class="tab-pane fade">
                    <p></p>
                </div>
                <div id="part3" class="tab-pane fade">
                    <p></p>
                </div>
                <div id="part4" class="tab-pane fade">
                    <p></p>
                </div>
            </div>

            <script>
                var data = [{
                    "Patient ID": "MB-0002",
                    "Sample ID": "MB-0002",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.63333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0005",
                    "Sample ID": "MB-0005",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 163.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0006",
                    "Sample ID": "MB-0006",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0010",
                    "Sample ID": "MB-0010",
                    "Nottingham prognostic index": 4.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 7.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0014",
                    "Sample ID": "MB-0014",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0020",
                    "Sample ID": "MB-0020",
                    "Nottingham prognostic index": 6.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 22.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 65,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0022",
                    "Sample ID": "MB-0022",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 89.08,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 99.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0667",
                    "Sample ID": "MB-0667",
                    "Nottingham prognostic index": 6.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.24,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 128,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0028",
                    "Sample ID": "MB-0028",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 86.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0035",
                    "Sample ID": "MB-0035",
                    "Nottingham prognostic index": 3.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 84.22,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 36.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0036",
                    "Sample ID": "MB-0036",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 85.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0039",
                    "Sample ID": "MB-0039",
                    "Nottingham prognostic index": 2.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 70.91,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 163.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 21,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0045",
                    "Sample ID": "MB-0045",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0046",
                    "Sample ID": "MB-0046",
                    "Nottingham prognostic index": 6.072,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 36,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0048",
                    "Sample ID": "MB-0048",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.46,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 103.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0050",
                    "Sample ID": "MB-0050",
                    "Nottingham prognostic index": 4.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.64,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 75.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 33,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0053",
                    "Sample ID": "MB-0053",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 161.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0054",
                    "Sample ID": "MB-0054",
                    "Nottingham prognostic index": 4.072,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 160.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 36,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0056",
                    "Sample ID": "MB-0056",
                    "Nottingham prognostic index": 3.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.62,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 62.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 29,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0059",
                    "Sample ID": "MB-0059",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.58,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 160.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0060",
                    "Sample ID": "MB-0060",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0062",
                    "Sample ID": "MB-0062",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.14,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 153.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0066",
                    "Sample ID": "MB-0066",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 157.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0068",
                    "Sample ID": "MB-0068",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 51.01,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 103.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 12,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0071",
                    "Sample ID": "MB-0071",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.42,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 131,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0079",
                    "Sample ID": "MB-0079",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 28.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0081",
                    "Sample ID": "MB-0081",
                    "Nottingham prognostic index": 3.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 69.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0083",
                    "Sample ID": "MB-0083",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.85,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 86.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0093",
                    "Sample ID": "MB-0093",
                    "Nottingham prognostic index": 5.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.55,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 153.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0095",
                    "Sample ID": "MB-0095",
                    "Nottingham prognostic index": 4.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0097",
                    "Sample ID": "MB-0097",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0099",
                    "Sample ID": "MB-0099",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.58,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 132.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0100",
                    "Sample ID": "MB-0100",
                    "Nottingham prognostic index": 4.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 8.066666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0101",
                    "Sample ID": "MB-0101",
                    "Nottingham prognostic index": 3.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.89,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 148.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 34,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0102",
                    "Sample ID": "MB-0102",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.38,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 140.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0106",
                    "Sample ID": "MB-0106",
                    "Nottingham prognostic index": 4.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 49.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 70,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0107",
                    "Sample ID": "MB-0107",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 158.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0109",
                    "Sample ID": "MB-0109",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 82.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 112.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0110",
                    "Sample ID": "MB-0110",
                    "Nottingham prognostic index": 2.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Phyllodes Tumor of the Breast",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 45.73,
                    "Oncotree Code": "PT",
                    "Overall Survival (Months)": 157.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "PHYL",
                    "Tumor Size": 70,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0111",
                    "Sample ID": "MB-0111",
                    "Nottingham prognostic index": 2.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 54.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 127.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0112",
                    "Sample ID": "MB-0112",
                    "Nottingham prognostic index": 6.3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.89,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 39.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 150,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0114",
                    "Sample ID": "MB-0114",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 13.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0115",
                    "Sample ID": "MB-0115",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 66.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0116",
                    "Sample ID": "MB-0116",
                    "Nottingham prognostic index": 4.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.55,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 122.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0117",
                    "Sample ID": "MB-0117",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.07,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 2.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0119",
                    "Sample ID": "MB-0119",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 95.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0121",
                    "Sample ID": "MB-0121",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 152.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0122",
                    "Sample ID": "MB-0122",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.95,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 138.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0123",
                    "Sample ID": "MB-0123",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0125",
                    "Sample ID": "MB-0125",
                    "Nottingham prognostic index": 2.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 73.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 1.266666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 9,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0126",
                    "Sample ID": "MB-0126",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 127.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0127",
                    "Sample ID": "MB-0127",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0128",
                    "Sample ID": "MB-0128",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 137.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0129",
                    "Sample ID": "MB-0129",
                    "Nottingham prognostic index": 6.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0130",
                    "Sample ID": "MB-0130",
                    "Nottingham prognostic index": 2.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 56.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 153.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0131",
                    "Sample ID": "MB-0131",
                    "Nottingham prognostic index": 4.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 66.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0133",
                    "Sample ID": "MB-0133",
                    "Nottingham prognostic index": 3.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.89,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 151,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 80,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0134",
                    "Sample ID": "MB-0134",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 12.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0135",
                    "Sample ID": "MB-0135",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 116.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0136",
                    "Sample ID": "MB-0136",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0138",
                    "Sample ID": "MB-0138",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.33,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 150.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0139",
                    "Sample ID": "MB-0139",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.62,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 109.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0140",
                    "Sample ID": "MB-0140",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.07,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 147.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0142",
                    "Sample ID": "MB-0142",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.99,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 12.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0143",
                    "Sample ID": "MB-0143",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 54.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0144",
                    "Sample ID": "MB-0144",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 152.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0145",
                    "Sample ID": "MB-0145",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.4,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 147.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0146",
                    "Sample ID": "MB-0146",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0147",
                    "Sample ID": "MB-0147",
                    "Nottingham prognostic index": 5.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.28,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 51.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 38,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0148",
                    "Sample ID": "MB-0148",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 1.766666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0149",
                    "Sample ID": "MB-0149",
                    "Nottingham prognostic index": 4.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0150",
                    "Sample ID": "MB-0150",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.22,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 111.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0151",
                    "Sample ID": "MB-0151",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0152",
                    "Sample ID": "MB-0152",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 63.03333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0153",
                    "Sample ID": "MB-0153",
                    "Nottingham prognostic index": 1.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Phyllodes Tumor of the Breast",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 67.12,
                    "Oncotree Code": "PT",
                    "Overall Survival (Months)": 148.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "PHYL",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0154",
                    "Sample ID": "MB-0154",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0155",
                    "Sample ID": "MB-0155",
                    "Nottingham prognostic index": 2.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 62.72,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 59.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 9,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0156",
                    "Sample ID": "MB-0156",
                    "Nottingham prognostic index": 2.004,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 60.85,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 2.866666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 2,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0158",
                    "Sample ID": "MB-0158",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.43,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 192.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0159",
                    "Sample ID": "MB-0159",
                    "Nottingham prognostic index": 2.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 51.04,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 75.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 23,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0160",
                    "Sample ID": "MB-0160",
                    "Nottingham prognostic index": 1.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Phyllodes Tumor of the Breast",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 36.66,
                    "Oncotree Code": "PT",
                    "Overall Survival (Months)": 143.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "PHYL",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0162",
                    "Sample ID": "MB-0162",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0163",
                    "Sample ID": "MB-0163",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 84.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0164",
                    "Sample ID": "MB-0164",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 10.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0165",
                    "Sample ID": "MB-0165",
                    "Nottingham prognostic index": 6.104,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 47.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 52,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0166",
                    "Sample ID": "MB-0166",
                    "Nottingham prognostic index": 5.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0167",
                    "Sample ID": "MB-0167",
                    "Nottingham prognostic index": 5.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 38,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0168",
                    "Sample ID": "MB-0168",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0169",
                    "Sample ID": "MB-0169",
                    "Nottingham prognostic index": 3.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.28,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 145.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 39,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0170",
                    "Sample ID": "MB-0170",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 83.35,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 93.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0171",
                    "Sample ID": "MB-0171",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.57,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 5.433333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0172",
                    "Sample ID": "MB-0172",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 138.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0173",
                    "Sample ID": "MB-0173",
                    "Nottingham prognostic index": 6.088,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 3.766666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 44,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0175",
                    "Sample ID": "MB-0175",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 69.51,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 72.36666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0176",
                    "Sample ID": "MB-0176",
                    "Nottingham prognostic index": 6.072,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 113.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 36,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0177",
                    "Sample ID": "MB-0177",
                    "Nottingham prognostic index": 4.088,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 85.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 44,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0178",
                    "Sample ID": "MB-0178",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0179",
                    "Sample ID": "MB-0179",
                    "Nottingham prognostic index": 6.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 17.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0180",
                    "Sample ID": "MB-0180",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0181",
                    "Sample ID": "MB-0181",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.96666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0184",
                    "Sample ID": "MB-0184",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.41,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 109.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0185",
                    "Sample ID": "MB-0185",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.84,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 43.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0188",
                    "Sample ID": "MB-0188",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.65,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 31.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0189",
                    "Sample ID": "MB-0189",
                    "Nottingham prognostic index": 6.096,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 9.066666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 48,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0191",
                    "Sample ID": "MB-0191",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 81.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0192",
                    "Sample ID": "MB-0192",
                    "Nottingham prognostic index": 2.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 62.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0193",
                    "Sample ID": "MB-0193",
                    "Nottingham prognostic index": 6.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0194",
                    "Sample ID": "MB-0194",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0195",
                    "Sample ID": "MB-0195",
                    "Nottingham prognostic index": 6.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0197",
                    "Sample ID": "MB-0197",
                    "Nottingham prognostic index": 5.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.73333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0198",
                    "Sample ID": "MB-0198",
                    "Nottingham prognostic index": 6.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.37,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 144.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0199",
                    "Sample ID": "MB-0199",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.56,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 144.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0393",
                    "Sample ID": "MB-0393",
                    "Nottingham prognostic index": 6.106,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 20.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 53,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0394",
                    "Sample ID": "MB-0394",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.48,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 64.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0395",
                    "Sample ID": "MB-0395",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 29,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0220",
                    "Sample ID": "MB-0220",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0226",
                    "Sample ID": "MB-0226",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.63333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0228",
                    "Sample ID": "MB-0228",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.35,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 10.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0230",
                    "Sample ID": "MB-0230",
                    "Nottingham prognostic index": 1.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Ductal Carcinoma In Situ",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 41.98,
                    "Oncotree Code": "DCIS",
                    "Overall Survival (Months)": 200.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 35,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0231",
                    "Sample ID": "MB-0231",
                    "Nottingham prognostic index": 1.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 71.57,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 19.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0232",
                    "Sample ID": "MB-0232",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 207.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0238",
                    "Sample ID": "MB-0238",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0239",
                    "Sample ID": "MB-0239",
                    "Nottingham prognostic index": 2.092,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 77.85,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 85.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 46,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0241",
                    "Sample ID": "MB-0241",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 73.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0243",
                    "Sample ID": "MB-0243",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0244",
                    "Sample ID": "MB-0244",
                    "Nottingham prognostic index": 2.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 67.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0245",
                    "Sample ID": "MB-0245",
                    "Nottingham prognostic index": 1.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 54.76,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 164.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0247",
                    "Sample ID": "MB-0247",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0248",
                    "Sample ID": "MB-0248",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0253",
                    "Sample ID": "MB-0253",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 152.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0256",
                    "Sample ID": "MB-0256",
                    "Nottingham prognostic index": 2.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 53.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0257",
                    "Sample ID": "MB-0257",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0259",
                    "Sample ID": "MB-0259",
                    "Nottingham prognostic index": 6,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 11.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0260",
                    "Sample ID": "MB-0260",
                    "Nottingham prognostic index": 1.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 78.26,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 169.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0261",
                    "Sample ID": "MB-0261",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0263",
                    "Sample ID": "MB-0263",
                    "Nottingham prognostic index": 1.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 76.49,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 176.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0264",
                    "Sample ID": "MB-0264",
                    "Nottingham prognostic index": 5.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0265",
                    "Sample ID": "MB-0265",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 189.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0266",
                    "Sample ID": "MB-0266",
                    "Nottingham prognostic index": 1.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 84.88,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 90.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0269",
                    "Sample ID": "MB-0269",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0270",
                    "Sample ID": "MB-0270",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 29.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 337.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0273",
                    "Sample ID": "MB-0273",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.66,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 186.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0275",
                    "Sample ID": "MB-0275",
                    "Nottingham prognostic index": 2.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.94,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 186.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 9,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0278",
                    "Sample ID": "MB-0278",
                    "Nottingham prognostic index": 5.106,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 34.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 5.833333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 53,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0279",
                    "Sample ID": "MB-0279",
                    "Nottingham prognostic index": 2.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 69.52,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 168.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0280",
                    "Sample ID": "MB-0280",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.64,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 172.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0281",
                    "Sample ID": "MB-0281",
                    "Nottingham prognostic index": 1,
                    "Cancer Type": "Breast Sarcoma",
                    "Cancer Type Detailed": "Breast",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 52.79,
                    "Oncotree Code": "BREAST",
                    "Overall Survival (Months)": 72.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "BENIGN",
                    "Tumor Size": 0,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0282",
                    "Sample ID": "MB-0282",
                    "Nottingham prognostic index": 6.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.81,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 194.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0284",
                    "Sample ID": "MB-0284",
                    "Nottingham prognostic index": 1,
                    "Cancer Type": "Breast Sarcoma",
                    "Cancer Type Detailed": "Breast",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 51.42,
                    "Oncotree Code": "BREAST",
                    "Overall Survival (Months)": 0,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "BENIGN",
                    "Tumor Size": 0,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0285",
                    "Sample ID": "MB-0285",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.07,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 3.366666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0286",
                    "Sample ID": "MB-0286",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 192.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0288",
                    "Sample ID": "MB-0288",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.22,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 63.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0289",
                    "Sample ID": "MB-0289",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0292",
                    "Sample ID": "MB-0292",
                    "Nottingham prognostic index": 5.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0293",
                    "Sample ID": "MB-0293",
                    "Nottingham prognostic index": 2.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 51.62,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 64.36666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0294",
                    "Sample ID": "MB-0294",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 72.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0299",
                    "Sample ID": "MB-0299",
                    "Nottingham prognostic index": 1.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.83,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 188.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 25,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0301",
                    "Sample ID": "MB-0301",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 82.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0303",
                    "Sample ID": "MB-0303",
                    "Nottingham prognostic index": 4.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 60.13333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0304",
                    "Sample ID": "MB-0304",
                    "Nottingham prognostic index": 5.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 84.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0305",
                    "Sample ID": "MB-0305",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.62,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 63.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0306",
                    "Sample ID": "MB-0306",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 82.53,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 42.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0307",
                    "Sample ID": "MB-0307",
                    "Nottingham prognostic index": 6.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 177.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0308",
                    "Sample ID": "MB-0308",
                    "Nottingham prognostic index": 2.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 51.21,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 183.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0309",
                    "Sample ID": "MB-0309",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 89.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0310",
                    "Sample ID": "MB-0310",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0312",
                    "Sample ID": "MB-0312",
                    "Nottingham prognostic index": 3.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.49,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 169,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 33,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0314",
                    "Sample ID": "MB-0314",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 4.433333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0315",
                    "Sample ID": "MB-0315",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 186.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0316",
                    "Sample ID": "MB-0316",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0318",
                    "Sample ID": "MB-0318",
                    "Nottingham prognostic index": 1.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 58.01,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 168.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0365",
                    "Sample ID": "MB-0365",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.84,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 87.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0366",
                    "Sample ID": "MB-0366",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0367",
                    "Sample ID": "MB-0367",
                    "Nottingham prognostic index": 3.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 142.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 9,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0368",
                    "Sample ID": "MB-0368",
                    "Nottingham prognostic index": 6.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0369",
                    "Sample ID": "MB-0369",
                    "Nottingham prognostic index": 6.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.47,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 144.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0370",
                    "Sample ID": "MB-0370",
                    "Nottingham prognostic index": 6.094,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 93.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 47,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0371",
                    "Sample ID": "MB-0371",
                    "Nottingham prognostic index": 6.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0372",
                    "Sample ID": "MB-0372",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0373",
                    "Sample ID": "MB-0373",
                    "Nottingham prognostic index": 5.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0374",
                    "Sample ID": "MB-0374",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 34.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 1.433333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0375",
                    "Sample ID": "MB-0375",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 143.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0377",
                    "Sample ID": "MB-0377",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 134.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0378",
                    "Sample ID": "MB-0378",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 97.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0379",
                    "Sample ID": "MB-0379",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.22,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 135.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0380",
                    "Sample ID": "MB-0380",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 69.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0381",
                    "Sample ID": "MB-0381",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 130.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0382",
                    "Sample ID": "MB-0382",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 136.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0383",
                    "Sample ID": "MB-0383",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0384",
                    "Sample ID": "MB-0384",
                    "Nottingham prognostic index": 6.086,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 43,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0385",
                    "Sample ID": "MB-0385",
                    "Nottingham prognostic index": 6.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.58,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 36.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0388",
                    "Sample ID": "MB-0388",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 97.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0389",
                    "Sample ID": "MB-0389",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 96.96666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0390",
                    "Sample ID": "MB-0390",
                    "Nottingham prognostic index": 6.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.68,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 72.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0391",
                    "Sample ID": "MB-0391",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 142.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0869",
                    "Sample ID": "MB-0869",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 112.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0872",
                    "Sample ID": "MB-0872",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 152.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0874",
                    "Sample ID": "MB-0874",
                    "Nottingham prognostic index": 4.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0876",
                    "Sample ID": "MB-0876",
                    "Nottingham prognostic index": 1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 54.85,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 176.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 0,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0877",
                    "Sample ID": "MB-0877",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0880",
                    "Sample ID": "MB-0880",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 73.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 1.233333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0882",
                    "Sample ID": "MB-0882",
                    "Nottingham prognostic index": 4.094,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.39,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 42.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 47,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0884",
                    "Sample ID": "MB-0884",
                    "Nottingham prognostic index": 6.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 93.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0885",
                    "Sample ID": "MB-0885",
                    "Nottingham prognostic index": 2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Phyllodes Tumor of the Breast",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 52.21,
                    "Oncotree Code": "PT",
                    "Overall Survival (Months)": 69.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "PHYL",
                    "Tumor Size": 0,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0891",
                    "Sample ID": "MB-0891",
                    "Nottingham prognostic index": 3.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 83.68,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 149.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 37,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0893",
                    "Sample ID": "MB-0893",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0895",
                    "Sample ID": "MB-0895",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0897",
                    "Sample ID": "MB-0897",
                    "Nottingham prognostic index": 4.092,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 41.32,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 30.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 46,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0899",
                    "Sample ID": "MB-0899",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0901",
                    "Sample ID": "MB-0901",
                    "Nottingham prognostic index": 5.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 136.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 33,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0904",
                    "Sample ID": "MB-0904",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 83.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0906",
                    "Sample ID": "MB-0906",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 63.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0907",
                    "Sample ID": "MB-0907",
                    "Nottingham prognostic index": 2.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 72.14,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 119.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 37,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0396",
                    "Sample ID": "MB-0396",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 60.66666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0397",
                    "Sample ID": "MB-0397",
                    "Nottingham prognostic index": 2.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.56,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 57.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0398",
                    "Sample ID": "MB-0398",
                    "Nottingham prognostic index": 6.084,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 42,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0399",
                    "Sample ID": "MB-0399",
                    "Nottingham prognostic index": 6.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 135.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0400",
                    "Sample ID": "MB-0400",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0401",
                    "Sample ID": "MB-0401",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 26.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0402",
                    "Sample ID": "MB-0402",
                    "Nottingham prognostic index": 2.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 73.06,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 99.73333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0403",
                    "Sample ID": "MB-0403",
                    "Nottingham prognostic index": 2,
                    "Cancer Type": "Breast Sarcoma",
                    "Cancer Type Detailed": "Breast",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 58.96,
                    "Oncotree Code": "BREAST",
                    "Overall Survival (Months)": 141,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "BENIGN",
                    "Tumor Size": 0,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0404",
                    "Sample ID": "MB-0404",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 63.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0405",
                    "Sample ID": "MB-0405",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.85,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 59.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0408",
                    "Sample ID": "MB-0408",
                    "Nottingham prognostic index": 5.094,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.01,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 101.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 47,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0410",
                    "Sample ID": "MB-0410",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.41,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 63,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0411",
                    "Sample ID": "MB-0411",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0412",
                    "Sample ID": "MB-0412",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 136.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0413",
                    "Sample ID": "MB-0413",
                    "Nottingham prognostic index": 6.094,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 47,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0414",
                    "Sample ID": "MB-0414",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 76.63333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0417",
                    "Sample ID": "MB-0417",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 6.266666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0418",
                    "Sample ID": "MB-0418",
                    "Nottingham prognostic index": 5.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0419",
                    "Sample ID": "MB-0419",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0200",
                    "Sample ID": "MB-0200",
                    "Nottingham prognostic index": 4.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 38,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0201",
                    "Sample ID": "MB-0201",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0202",
                    "Sample ID": "MB-0202",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0203",
                    "Sample ID": "MB-0203",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 86.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 58.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0204",
                    "Sample ID": "MB-0204",
                    "Nottingham prognostic index": 2.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 79.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0205",
                    "Sample ID": "MB-0205",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.56,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 144.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0206",
                    "Sample ID": "MB-0206",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.02,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 141.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0207",
                    "Sample ID": "MB-0207",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 173.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0209",
                    "Sample ID": "MB-0209",
                    "Nottingham prognostic index": 3.006,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 82.36666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 3,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0210",
                    "Sample ID": "MB-0210",
                    "Nottingham prognostic index": 5.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.14,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 144.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 5,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0211",
                    "Sample ID": "MB-0211",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0214",
                    "Sample ID": "MB-0214",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0215",
                    "Sample ID": "MB-0215",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.63,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 122.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0218",
                    "Sample ID": "MB-0218",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0420",
                    "Sample ID": "MB-0420",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 34.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 76.73333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0421",
                    "Sample ID": "MB-0421",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 92.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0422",
                    "Sample ID": "MB-0422",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 33.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0423",
                    "Sample ID": "MB-0423",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.1,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 138.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0424",
                    "Sample ID": "MB-0424",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 9.833333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0425",
                    "Sample ID": "MB-0425",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 83.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0426",
                    "Sample ID": "MB-0426",
                    "Nottingham prognostic index": 4.084,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 42,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0427",
                    "Sample ID": "MB-0427",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.89,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 116.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0428",
                    "Sample ID": "MB-0428",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.93333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0429",
                    "Sample ID": "MB-0429",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.86,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 74.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0431",
                    "Sample ID": "MB-0431",
                    "Nottingham prognostic index": 4.114,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.61,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 85.13333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 57,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0432",
                    "Sample ID": "MB-0432",
                    "Nottingham prognostic index": 2.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 60.07,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 105.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0434",
                    "Sample ID": "MB-0434",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0435",
                    "Sample ID": "MB-0435",
                    "Nottingham prognostic index": 3.008,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.29,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 110.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 4,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0436",
                    "Sample ID": "MB-0436",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 88.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0437",
                    "Sample ID": "MB-0437",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0438",
                    "Sample ID": "MB-0438",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 135.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0439",
                    "Sample ID": "MB-0439",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.32,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 112.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0440",
                    "Sample ID": "MB-0440",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 100.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0443",
                    "Sample ID": "MB-0443",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.03333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0445",
                    "Sample ID": "MB-0445",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0446",
                    "Sample ID": "MB-0446",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 72.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0448",
                    "Sample ID": "MB-0448",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.45,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 29.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 13,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0449",
                    "Sample ID": "MB-0449",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 54.38,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 112.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0451",
                    "Sample ID": "MB-0451",
                    "Nottingham prognostic index": 2.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.06666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0452",
                    "Sample ID": "MB-0452",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0453",
                    "Sample ID": "MB-0453",
                    "Nottingham prognostic index": 6.2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 100,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0454",
                    "Sample ID": "MB-0454",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 90.02,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 46.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0455",
                    "Sample ID": "MB-0455",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 99.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0458",
                    "Sample ID": "MB-0458",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.28,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 134.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0459",
                    "Sample ID": "MB-0459",
                    "Nottingham prognostic index": 5.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0460",
                    "Sample ID": "MB-0460",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.44,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 114,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0462",
                    "Sample ID": "MB-0462",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0463",
                    "Sample ID": "MB-0463",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0464",
                    "Sample ID": "MB-0464",
                    "Nottingham prognostic index": 6.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0465",
                    "Sample ID": "MB-0465",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 87.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 28.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0466",
                    "Sample ID": "MB-0466",
                    "Nottingham prognostic index": 5.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 33.97,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 70,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0467",
                    "Sample ID": "MB-0467",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 105.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0468",
                    "Sample ID": "MB-0468",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 129.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0469",
                    "Sample ID": "MB-0469",
                    "Nottingham prognostic index": 5.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0470",
                    "Sample ID": "MB-0470",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.78,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 88.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0471",
                    "Sample ID": "MB-0471",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 107.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0472",
                    "Sample ID": "MB-0472",
                    "Nottingham prognostic index": 1.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 59.34,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 27.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 11,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0474",
                    "Sample ID": "MB-0474",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.29,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 111.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 80,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0475",
                    "Sample ID": "MB-0475",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 130.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0476",
                    "Sample ID": "MB-0476",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 130.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0406",
                    "Sample ID": "MB-0406",
                    "Nottingham prognostic index": 6.36,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 96.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 180,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0478",
                    "Sample ID": "MB-0478",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0479",
                    "Sample ID": "MB-0479",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0480",
                    "Sample ID": "MB-0480",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 94.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0481",
                    "Sample ID": "MB-0481",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0483",
                    "Sample ID": "MB-0483",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 74.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0484",
                    "Sample ID": "MB-0484",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 82.63333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0485",
                    "Sample ID": "MB-0485",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.78,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 36.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0486",
                    "Sample ID": "MB-0486",
                    "Nottingham prognostic index": 4.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.96666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0487",
                    "Sample ID": "MB-0487",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.36,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 86.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0488",
                    "Sample ID": "MB-0488",
                    "Nottingham prognostic index": 2.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 50.64,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 112.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0489",
                    "Sample ID": "MB-0489",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0490",
                    "Sample ID": "MB-0490",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0491",
                    "Sample ID": "MB-0491",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.4,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 125.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0492",
                    "Sample ID": "MB-0492",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0494",
                    "Sample ID": "MB-0494",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0495",
                    "Sample ID": "MB-0495",
                    "Nottingham prognostic index": 6.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0496",
                    "Sample ID": "MB-0496",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 60,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 130.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0497",
                    "Sample ID": "MB-0497",
                    "Nottingham prognostic index": 3.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 73.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0499",
                    "Sample ID": "MB-0499",
                    "Nottingham prognostic index": 3.008,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.15,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 131.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 4,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0500",
                    "Sample ID": "MB-0500",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 67.46666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0501",
                    "Sample ID": "MB-0501",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0502",
                    "Sample ID": "MB-0502",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 82.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0503",
                    "Sample ID": "MB-0503",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.77,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 101.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0504",
                    "Sample ID": "MB-0504",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.16,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 130.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0506",
                    "Sample ID": "MB-0506",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0507",
                    "Sample ID": "MB-0507",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0508",
                    "Sample ID": "MB-0508",
                    "Nottingham prognostic index": 3.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0509",
                    "Sample ID": "MB-0509",
                    "Nottingham prognostic index": 4.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 115.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0510",
                    "Sample ID": "MB-0510",
                    "Nottingham prognostic index": 5.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0511",
                    "Sample ID": "MB-0511",
                    "Nottingham prognostic index": 3.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0512",
                    "Sample ID": "MB-0512",
                    "Nottingham prognostic index": 2.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 56.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 121.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0513",
                    "Sample ID": "MB-0513",
                    "Nottingham prognostic index": 4.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0514",
                    "Sample ID": "MB-0514",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.89,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 13.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0516",
                    "Sample ID": "MB-0516",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0517",
                    "Sample ID": "MB-0517",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0574",
                    "Sample ID": "MB-0574",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0575",
                    "Sample ID": "MB-0575",
                    "Nottingham prognostic index": 5.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.1,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 128.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 55,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0576",
                    "Sample ID": "MB-0576",
                    "Nottingham prognostic index": 6.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0577",
                    "Sample ID": "MB-0577",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.42,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 65.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0578",
                    "Sample ID": "MB-0578",
                    "Nottingham prognostic index": 5.084,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.64,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 110.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 42,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0579",
                    "Sample ID": "MB-0579",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 92.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0580",
                    "Sample ID": "MB-0580",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0581",
                    "Sample ID": "MB-0581",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 96.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 7.866666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0582",
                    "Sample ID": "MB-0582",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 84.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0583",
                    "Sample ID": "MB-0583",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.63333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0584",
                    "Sample ID": "MB-0584",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0585",
                    "Sample ID": "MB-0585",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 106.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0586",
                    "Sample ID": "MB-0586",
                    "Nottingham prognostic index": 4.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.99,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 77.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 65,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0587",
                    "Sample ID": "MB-0587",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.41,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 91.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0588",
                    "Sample ID": "MB-0588",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0589",
                    "Sample ID": "MB-0589",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0590",
                    "Sample ID": "MB-0590",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 72.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0591",
                    "Sample ID": "MB-0591",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0592",
                    "Sample ID": "MB-0592",
                    "Nottingham prognostic index": 1.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 74.94,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 74.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 55,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0594",
                    "Sample ID": "MB-0594",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0596",
                    "Sample ID": "MB-0596",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.48,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 100.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0597",
                    "Sample ID": "MB-0597",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 113.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0598",
                    "Sample ID": "MB-0598",
                    "Nottingham prognostic index": 5.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0599",
                    "Sample ID": "MB-0599",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0600",
                    "Sample ID": "MB-0600",
                    "Nottingham prognostic index": 6.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 111,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0601",
                    "Sample ID": "MB-0601",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 32.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 29.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0603",
                    "Sample ID": "MB-0603",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 121.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0605",
                    "Sample ID": "MB-0605",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.08,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 114.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0606",
                    "Sample ID": "MB-0606",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 83.19,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 27.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0607",
                    "Sample ID": "MB-0607",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 87.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0608",
                    "Sample ID": "MB-0608",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.81,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 63.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0609",
                    "Sample ID": "MB-0609",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0610",
                    "Sample ID": "MB-0610",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 76.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0611",
                    "Sample ID": "MB-0611",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0613",
                    "Sample ID": "MB-0613",
                    "Nottingham prognostic index": 3.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.2,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 48.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0614",
                    "Sample ID": "MB-0614",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0615",
                    "Sample ID": "MB-0615",
                    "Nottingham prognostic index": 4.006,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 38.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0616",
                    "Sample ID": "MB-0616",
                    "Nottingham prognostic index": 5.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.98,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 29.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 38,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0617",
                    "Sample ID": "MB-0617",
                    "Nottingham prognostic index": 2.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 72.14,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 92.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0618",
                    "Sample ID": "MB-0618",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0619",
                    "Sample ID": "MB-0619",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.9,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 94.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0620",
                    "Sample ID": "MB-0620",
                    "Nottingham prognostic index": 5.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.97,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 112.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0621",
                    "Sample ID": "MB-0621",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.04,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 33.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0623",
                    "Sample ID": "MB-0623",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0624",
                    "Sample ID": "MB-0624",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64.03333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0626",
                    "Sample ID": "MB-0626",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0627",
                    "Sample ID": "MB-0627",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 0.766666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0628",
                    "Sample ID": "MB-0628",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 105.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0630",
                    "Sample ID": "MB-0630",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0631",
                    "Sample ID": "MB-0631",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 84.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 47.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0632",
                    "Sample ID": "MB-0632",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 56.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0634",
                    "Sample ID": "MB-0634",
                    "Nottingham prognostic index": 4.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.99,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 17.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0635",
                    "Sample ID": "MB-0635",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 88,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0636",
                    "Sample ID": "MB-0636",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 26.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0637",
                    "Sample ID": "MB-0637",
                    "Nottingham prognostic index": 4.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.66666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0638",
                    "Sample ID": "MB-0638",
                    "Nottingham prognostic index": 4.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 103.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0639",
                    "Sample ID": "MB-0639",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0640",
                    "Sample ID": "MB-0640",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0641",
                    "Sample ID": "MB-0641",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0642",
                    "Sample ID": "MB-0642",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 79.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0643",
                    "Sample ID": "MB-0643",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0644",
                    "Sample ID": "MB-0644",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 93.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0646",
                    "Sample ID": "MB-0646",
                    "Nottingham prognostic index": 5.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.06,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 15.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 33,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0649",
                    "Sample ID": "MB-0649",
                    "Nottingham prognostic index": 4.016,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 60.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.43333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 8,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0650",
                    "Sample ID": "MB-0650",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 25.53333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0652",
                    "Sample ID": "MB-0652",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 96.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0653",
                    "Sample ID": "MB-0653",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.95,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 24.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0654",
                    "Sample ID": "MB-0654",
                    "Nottingham prognostic index": 2.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 82.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 69.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0655",
                    "Sample ID": "MB-0655",
                    "Nottingham prognostic index": 1.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 69.73,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 111.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 60,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0656",
                    "Sample ID": "MB-0656",
                    "Nottingham prognostic index": 4.2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 100,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0657",
                    "Sample ID": "MB-0657",
                    "Nottingham prognostic index": 3.2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.65,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 30.43333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 100,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0658",
                    "Sample ID": "MB-0658",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 97.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0659",
                    "Sample ID": "MB-0659",
                    "Nottingham prognostic index": 3.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.87,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 23.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 45,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0660",
                    "Sample ID": "MB-0660",
                    "Nottingham prognostic index": 6.32,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.43,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 18.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 160,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0661",
                    "Sample ID": "MB-0661",
                    "Nottingham prognostic index": 3.016,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 20,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 8,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0662",
                    "Sample ID": "MB-0662",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 69.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0663",
                    "Sample ID": "MB-0663",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.36666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0664",
                    "Sample ID": "MB-0664",
                    "Nottingham prognostic index": 6.168,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 11.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 84,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0666",
                    "Sample ID": "MB-0666",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0225",
                    "Sample ID": "MB-0225",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 212.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0227",
                    "Sample ID": "MB-0227",
                    "Nottingham prognostic index": 3.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0234",
                    "Sample ID": "MB-0234",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 56.27,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 94.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0236",
                    "Sample ID": "MB-0236",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 205.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0242",
                    "Sample ID": "MB-0242",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0249",
                    "Sample ID": "MB-0249",
                    "Nottingham prognostic index": 4.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 188.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0531",
                    "Sample ID": "MB-0531",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 163.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0535",
                    "Sample ID": "MB-0535",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0536",
                    "Sample ID": "MB-0536",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 147.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0537",
                    "Sample ID": "MB-0537",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 113.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0290",
                    "Sample ID": "MB-0290",
                    "Nottingham prognostic index": 2.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 49.92,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 199.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0538",
                    "Sample ID": "MB-0538",
                    "Nottingham prognostic index": 6.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 37,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0295",
                    "Sample ID": "MB-0295",
                    "Nottingham prognostic index": 3.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 47.13,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 164.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 9,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0540",
                    "Sample ID": "MB-0540",
                    "Nottingham prognostic index": 2.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 66.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0543",
                    "Sample ID": "MB-0543",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.9,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 154.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0327",
                    "Sample ID": "MB-0327",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.73,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 187.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0564",
                    "Sample ID": "MB-0564",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.39,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 37.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0568",
                    "Sample ID": "MB-0568",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 181.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0344",
                    "Sample ID": "MB-0344",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.75,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 152.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0347",
                    "Sample ID": "MB-0347",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.24,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 205.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0350",
                    "Sample ID": "MB-0350",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.05,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 46.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 80,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0352",
                    "Sample ID": "MB-0352",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0359",
                    "Sample ID": "MB-0359",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0361",
                    "Sample ID": "MB-0361",
                    "Nottingham prognostic index": 6.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3363",
                    "Sample ID": "MB-3363",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 10.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3365",
                    "Sample ID": "MB-3365",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 241.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3367",
                    "Sample ID": "MB-3367",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.62,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 179.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 23,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3378",
                    "Sample ID": "MB-3378",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.5,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 87.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3379",
                    "Sample ID": "MB-3379",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.99,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 113.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3381",
                    "Sample ID": "MB-3381",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 236.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0505",
                    "Sample ID": "MB-0505",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 56.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 60.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3383",
                    "Sample ID": "MB-3383",
                    "Nottingham prognostic index": 6.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3386",
                    "Sample ID": "MB-3386",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3388",
                    "Sample ID": "MB-3388",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3395",
                    "Sample ID": "MB-3395",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 243.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3396",
                    "Sample ID": "MB-3396",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 226.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3402",
                    "Sample ID": "MB-3402",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3403",
                    "Sample ID": "MB-3403",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 138.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3412",
                    "Sample ID": "MB-3412",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3417",
                    "Sample ID": "MB-3417",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 103.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3429",
                    "Sample ID": "MB-3429",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.08,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 243.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0521",
                    "Sample ID": "MB-0521",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.2,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 212.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0522",
                    "Sample ID": "MB-0522",
                    "Nottingham prognostic index": 2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Ductal Carcinoma In Situ",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 54.08,
                    "Oncotree Code": "DCIS",
                    "Overall Survival (Months)": 2.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 0,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0525",
                    "Sample ID": "MB-0525",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0526",
                    "Sample ID": "MB-0526",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0527",
                    "Sample ID": "MB-0527",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 109.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0528",
                    "Sample ID": "MB-0528",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0529",
                    "Sample ID": "MB-0529",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3462",
                    "Sample ID": "MB-3462",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 234.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0532",
                    "Sample ID": "MB-0532",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 143.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0534",
                    "Sample ID": "MB-0534",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3470",
                    "Sample ID": "MB-3470",
                    "Nottingham prognostic index": 5.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3476",
                    "Sample ID": "MB-3476",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.59,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 159.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3479",
                    "Sample ID": "MB-3479",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 231.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3487",
                    "Sample ID": "MB-3487",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 237.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0539",
                    "Sample ID": "MB-0539",
                    "Nottingham prognostic index": 1.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 64.21,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 85.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 20,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3490",
                    "Sample ID": "MB-3490",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 45.74,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 102.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0541",
                    "Sample ID": "MB-0541",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3500",
                    "Sample ID": "MB-3500",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 239.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0544",
                    "Sample ID": "MB-0544",
                    "Nottingham prognostic index": 5.104,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.46,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 79.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 52,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0545",
                    "Sample ID": "MB-0545",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 41.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0546",
                    "Sample ID": "MB-0546",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.45,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 193.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0550",
                    "Sample ID": "MB-0550",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0551",
                    "Sample ID": "MB-0551",
                    "Nottingham prognostic index": 3.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.32,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 51.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0552",
                    "Sample ID": "MB-0552",
                    "Nottingham prognostic index": 6.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 68.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0553",
                    "Sample ID": "MB-0553",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 86.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0554",
                    "Sample ID": "MB-0554",
                    "Nottingham prognostic index": 2.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 82.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0120",
                    "Sample ID": "MB-0120",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 29.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0559",
                    "Sample ID": "MB-0559",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 161.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3556",
                    "Sample ID": "MB-3556",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 80,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3567",
                    "Sample ID": "MB-3567",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.95,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 236.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0570",
                    "Sample ID": "MB-0570",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 272.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0571",
                    "Sample ID": "MB-0571",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0573",
                    "Sample ID": "MB-0573",
                    "Nottingham prognostic index": 3.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.22,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 163.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 65,
                    "Tumor Stage": 0,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3614",
                    "Sample ID": "MB-3614",
                    "Nottingham prognostic index": 5.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 235.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3702",
                    "Sample ID": "MB-3702",
                    "Nottingham prognostic index": 5.011,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 230.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 5.5,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3706",
                    "Sample ID": "MB-3706",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3707",
                    "Sample ID": "MB-3707",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3711",
                    "Sample ID": "MB-3711",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 41.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 222.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3748",
                    "Sample ID": "MB-3748",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3752",
                    "Sample ID": "MB-3752",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.98,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 75.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3754",
                    "Sample ID": "MB-3754",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 92.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3781",
                    "Sample ID": "MB-3781",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.16,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 224.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3797",
                    "Sample ID": "MB-3797",
                    "Nottingham prognostic index": 1.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.72,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 228.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "",
                    "Tumor Size": 24,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3823",
                    "Sample ID": "MB-3823",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "UNDEF",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.78,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 222.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3824",
                    "Sample ID": "MB-3824",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 126.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3838",
                    "Sample ID": "MB-3838",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 134.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3840",
                    "Sample ID": "MB-3840",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 287.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3842",
                    "Sample ID": "MB-3842",
                    "Nottingham prognostic index": 5.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 226.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3850",
                    "Sample ID": "MB-3850",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.89,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 72.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3852",
                    "Sample ID": "MB-3852",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 225.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3854",
                    "Sample ID": "MB-3854",
                    "Nottingham prognostic index": 2.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.82,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 99.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3865",
                    "Sample ID": "MB-3865",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 49.37,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 199.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3871",
                    "Sample ID": "MB-3871",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.03,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 172.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3874",
                    "Sample ID": "MB-3874",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 35.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 186.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3978",
                    "Sample ID": "MB-3978",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 100.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4000",
                    "Sample ID": "MB-4000",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.96,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 28.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4001",
                    "Sample ID": "MB-4001",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4003",
                    "Sample ID": "MB-4003",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 106.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4005",
                    "Sample ID": "MB-4005",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.37,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 188.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4008",
                    "Sample ID": "MB-4008",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4010",
                    "Sample ID": "MB-4010",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 11.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4011",
                    "Sample ID": "MB-4011",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "UNDEF",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4012",
                    "Sample ID": "MB-4012",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 63.23,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 277.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4015",
                    "Sample ID": "MB-4015",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 11.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4017",
                    "Sample ID": "MB-4017",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4018",
                    "Sample ID": "MB-4018",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 105.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4024",
                    "Sample ID": "MB-4024",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4033",
                    "Sample ID": "MB-4033",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.17,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 15.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 22,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4046",
                    "Sample ID": "MB-4046",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 298.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4091",
                    "Sample ID": "MB-4091",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 281.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4098",
                    "Sample ID": "MB-4098",
                    "Nottingham prognostic index": 2.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.55,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 176.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4120",
                    "Sample ID": "MB-4120",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 217.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4126",
                    "Sample ID": "MB-4126",
                    "Nottingham prognostic index": 1.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 73.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4127",
                    "Sample ID": "MB-4127",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 258.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4139",
                    "Sample ID": "MB-4139",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 63.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 165.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4140",
                    "Sample ID": "MB-4140",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4141",
                    "Sample ID": "MB-4141",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 147.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4145",
                    "Sample ID": "MB-4145",
                    "Nottingham prognostic index": 1.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 60.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 217.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4146",
                    "Sample ID": "MB-4146",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.06,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 15.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4148",
                    "Sample ID": "MB-4148",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 63.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4154",
                    "Sample ID": "MB-4154",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4171",
                    "Sample ID": "MB-4171",
                    "Nottingham prognostic index": 4.086,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.21,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 184.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 43,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4173",
                    "Sample ID": "MB-4173",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 160.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4189",
                    "Sample ID": "MB-4189",
                    "Nottingham prognostic index": 2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 60.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 355.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-4212",
                    "Sample ID": "MB-4212",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 45.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 330.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4213",
                    "Sample ID": "MB-4213",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4222",
                    "Sample ID": "MB-4222",
                    "Nottingham prognostic index": 2.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4224",
                    "Sample ID": "MB-4224",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "NC",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4230",
                    "Sample ID": "MB-4230",
                    "Nottingham prognostic index": 3.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 115.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4233",
                    "Sample ID": "MB-4233",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4234",
                    "Sample ID": "MB-4234",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 253.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4235",
                    "Sample ID": "MB-4235",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 335.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4236",
                    "Sample ID": "MB-4236",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 203.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4250",
                    "Sample ID": "MB-4250",
                    "Nottingham prognostic index": 4.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 100.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4254",
                    "Sample ID": "MB-4254",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.7,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 178.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4264",
                    "Sample ID": "MB-4264",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 163.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4266",
                    "Sample ID": "MB-4266",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 28.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 33.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4270",
                    "Sample ID": "MB-4270",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 37.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4274",
                    "Sample ID": "MB-4274",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 59.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4276",
                    "Sample ID": "MB-4276",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4278",
                    "Sample ID": "MB-4278",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 244.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4281",
                    "Sample ID": "MB-4281",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 260.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4282",
                    "Sample ID": "MB-4282",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4283",
                    "Sample ID": "MB-4283",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4289",
                    "Sample ID": "MB-4289",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 65.49,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 96.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0221",
                    "Sample ID": "MB-0221",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 20.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0222",
                    "Sample ID": "MB-0222",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 50.31,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 212.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0223",
                    "Sample ID": "MB-0223",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0224",
                    "Sample ID": "MB-0224",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 176.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4303",
                    "Sample ID": "MB-4303",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4310",
                    "Sample ID": "MB-4310",
                    "Nottingham prognostic index": 2.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 265.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4313",
                    "Sample ID": "MB-4313",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 300.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0229",
                    "Sample ID": "MB-0229",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 45.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4318",
                    "Sample ID": "MB-4318",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 17.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4322",
                    "Sample ID": "MB-4322",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 196.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0233",
                    "Sample ID": "MB-0233",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 72.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4328",
                    "Sample ID": "MB-4328",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0235",
                    "Sample ID": "MB-0235",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 142.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4331",
                    "Sample ID": "MB-4331",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 235.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4332",
                    "Sample ID": "MB-4332",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 34.36,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 307.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4339",
                    "Sample ID": "MB-4339",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 173.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4341",
                    "Sample ID": "MB-4341",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 33.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4342",
                    "Sample ID": "MB-4342",
                    "Nottingham prognostic index": 2.124,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 73.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 232.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 62,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4343",
                    "Sample ID": "MB-4343",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 198.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2513",
                    "Sample ID": "MB-2513",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 59.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2517",
                    "Sample ID": "MB-2517",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 268.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2536",
                    "Sample ID": "MB-2536",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 54.11,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 47.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2556",
                    "Sample ID": "MB-2556",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.59,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 220.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2564",
                    "Sample ID": "MB-2564",
                    "Nottingham prognostic index": 2.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 52.98,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 285.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2610",
                    "Sample ID": "MB-2610",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.99,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 280.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2613",
                    "Sample ID": "MB-2613",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 163.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0258",
                    "Sample ID": "MB-0258",
                    "Nottingham prognostic index": 4.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.13333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2616",
                    "Sample ID": "MB-2616",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.07,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 219.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2617",
                    "Sample ID": "MB-2617",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2618",
                    "Sample ID": "MB-2618",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0262",
                    "Sample ID": "MB-0262",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 145.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2626",
                    "Sample ID": "MB-2626",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2629",
                    "Sample ID": "MB-2629",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 279.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2632",
                    "Sample ID": "MB-2632",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2634",
                    "Sample ID": "MB-2634",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 274.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2643",
                    "Sample ID": "MB-2643",
                    "Nottingham prognostic index": 3.006,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 34.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 52.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 3,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2645",
                    "Sample ID": "MB-2645",
                    "Nottingham prognostic index": 6.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0272",
                    "Sample ID": "MB-0272",
                    "Nottingham prognostic index": 6.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2686",
                    "Sample ID": "MB-2686",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 177.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2705",
                    "Sample ID": "MB-2705",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.78,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 163.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2708",
                    "Sample ID": "MB-2708",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.36,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 133.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2711",
                    "Sample ID": "MB-2711",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 201.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2712",
                    "Sample ID": "MB-2712",
                    "Nottingham prognostic index": 3.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 54.59,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 234.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 11,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2718",
                    "Sample ID": "MB-2718",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.94,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 278.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2721",
                    "Sample ID": "MB-2721",
                    "Nottingham prognostic index": 2.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 44.82,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 251.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 9,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2725",
                    "Sample ID": "MB-2725",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 44.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 236.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2728",
                    "Sample ID": "MB-2728",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 28.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2730",
                    "Sample ID": "MB-2730",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 133.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0287",
                    "Sample ID": "MB-0287",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 94.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2742",
                    "Sample ID": "MB-2742",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2744",
                    "Sample ID": "MB-2744",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 45.57,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 275.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2745",
                    "Sample ID": "MB-2745",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.85,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 168.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2749",
                    "Sample ID": "MB-2749",
                    "Nottingham prognostic index": 2.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 60.13,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 97.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2750",
                    "Sample ID": "MB-2750",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 47.48,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 145.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2752",
                    "Sample ID": "MB-2752",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.36,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 81.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2753",
                    "Sample ID": "MB-2753",
                    "Nottingham prognostic index": 5.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 30.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 274.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 37,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2754",
                    "Sample ID": "MB-2754",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.11,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 203.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2758",
                    "Sample ID": "MB-2758",
                    "Nottingham prognostic index": 6.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0302",
                    "Sample ID": "MB-0302",
                    "Nottingham prognostic index": 6.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 81.53,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 84.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2763",
                    "Sample ID": "MB-2763",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.32,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 275.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "MIXED NST AND A SPECIAL TYPE",
                    "Tumor Size": 26,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2764",
                    "Sample ID": "MB-2764",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 270.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2765",
                    "Sample ID": "MB-2765",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 227.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2767",
                    "Sample ID": "MB-2767",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 271.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2770",
                    "Sample ID": "MB-2770",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.32,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 274.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 45,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2771",
                    "Sample ID": "MB-2771",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2772",
                    "Sample ID": "MB-2772",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0311",
                    "Sample ID": "MB-0311",
                    "Nottingham prognostic index": 2.094,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 77.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 151.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 47,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2778",
                    "Sample ID": "MB-2778",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.76,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 181.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "NC",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0313",
                    "Sample ID": "MB-0313",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2781",
                    "Sample ID": "MB-2781",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.32,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 40.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2786",
                    "Sample ID": "MB-2786",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 68.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2790",
                    "Sample ID": "MB-2790",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.03,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 116.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0317",
                    "Sample ID": "MB-0317",
                    "Nottingham prognostic index": 4.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 151.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2792",
                    "Sample ID": "MB-2792",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0319",
                    "Sample ID": "MB-0319",
                    "Nottingham prognostic index": 5.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 92.14,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 40.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0320",
                    "Sample ID": "MB-0320",
                    "Nottingham prognostic index": 2.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 50.98,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 63.73333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0321",
                    "Sample ID": "MB-0321",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0322",
                    "Sample ID": "MB-0322",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 86.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0324",
                    "Sample ID": "MB-0324",
                    "Nottingham prognostic index": 6.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0325",
                    "Sample ID": "MB-0325",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 177.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2814",
                    "Sample ID": "MB-2814",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 231.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0328",
                    "Sample ID": "MB-0328",
                    "Nottingham prognostic index": 5.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0333",
                    "Sample ID": "MB-0333",
                    "Nottingham prognostic index": 1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 62.81,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 26.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0336",
                    "Sample ID": "MB-0336",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0339",
                    "Sample ID": "MB-0339",
                    "Nottingham prognostic index": 3.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 90.43,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 26.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0340",
                    "Sample ID": "MB-0340",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.97,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0341",
                    "Sample ID": "MB-0341",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0342",
                    "Sample ID": "MB-0342",
                    "Nottingham prognostic index": 3.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.96,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 125.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 29,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0343",
                    "Sample ID": "MB-0343",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2835",
                    "Sample ID": "MB-2835",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0345",
                    "Sample ID": "MB-0345",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 37.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 72.66666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0346",
                    "Sample ID": "MB-0346",
                    "Nottingham prognostic index": 6.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 32.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 20.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2842",
                    "Sample ID": "MB-2842",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0348",
                    "Sample ID": "MB-0348",
                    "Nottingham prognostic index": 2.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 81.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0349",
                    "Sample ID": "MB-0349",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2845",
                    "Sample ID": "MB-2845",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.8,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 264.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0351",
                    "Sample ID": "MB-0351",
                    "Nottingham prognostic index": 1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 69.53,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 195.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": null,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-2847",
                    "Sample ID": "MB-2847",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0353",
                    "Sample ID": "MB-0353",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 86.26,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 41.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0354",
                    "Sample ID": "MB-0354",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 11.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0356",
                    "Sample ID": "MB-0356",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.16,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 213.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0358",
                    "Sample ID": "MB-0358",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2853",
                    "Sample ID": "MB-2853",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 36.25,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 269.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 23,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0360",
                    "Sample ID": "MB-0360",
                    "Nottingham prognostic index": 3.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 83.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 132.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2857",
                    "Sample ID": "MB-2857",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 250.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0362",
                    "Sample ID": "MB-0362",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.79,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 47.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0363",
                    "Sample ID": "MB-0363",
                    "Nottingham prognostic index": 5.134,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.24,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 89.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 67,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0364",
                    "Sample ID": "MB-0364",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 176.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2895",
                    "Sample ID": "MB-2895",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 196.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2896",
                    "Sample ID": "MB-2896",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.18,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 237.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2900",
                    "Sample ID": "MB-2900",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.29,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 20.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2901",
                    "Sample ID": "MB-2901",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 218.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2904",
                    "Sample ID": "MB-2904",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 34.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2912",
                    "Sample ID": "MB-2912",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 267.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2916",
                    "Sample ID": "MB-2916",
                    "Nottingham prognostic index": 2.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 48.93,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 266.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2917",
                    "Sample ID": "MB-2917",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2919",
                    "Sample ID": "MB-2919",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.13,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 240.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2922",
                    "Sample ID": "MB-2922",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2923",
                    "Sample ID": "MB-2923",
                    "Nottingham prognostic index": 6.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 37,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2927",
                    "Sample ID": "MB-2927",
                    "Nottingham prognostic index": 2.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.14,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 263.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2929",
                    "Sample ID": "MB-2929",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 262.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2931",
                    "Sample ID": "MB-2931",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2932",
                    "Sample ID": "MB-2932",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2933",
                    "Sample ID": "MB-2933",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 44.08,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 161.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2939",
                    "Sample ID": "MB-2939",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2944",
                    "Sample ID": "MB-2944",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.97,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2947",
                    "Sample ID": "MB-2947",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 36.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 112,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2951",
                    "Sample ID": "MB-2951",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 39.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 263.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0386",
                    "Sample ID": "MB-0386",
                    "Nottingham prognostic index": 6.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 138.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2953",
                    "Sample ID": "MB-2953",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2954",
                    "Sample ID": "MB-2954",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 5.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2957",
                    "Sample ID": "MB-2957",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 31.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 262.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2960",
                    "Sample ID": "MB-2960",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 222.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0392",
                    "Sample ID": "MB-0392",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2964",
                    "Sample ID": "MB-2964",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 9.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2966",
                    "Sample ID": "MB-2966",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 265,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2969",
                    "Sample ID": "MB-2969",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 172.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2970",
                    "Sample ID": "MB-2970",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.49,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 252.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2971",
                    "Sample ID": "MB-2971",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 264.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2977",
                    "Sample ID": "MB-2977",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 40.02,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 110.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2983",
                    "Sample ID": "MB-2983",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.26,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 180.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2984",
                    "Sample ID": "MB-2984",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 261.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2990",
                    "Sample ID": "MB-2990",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 48.47,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 260,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2993",
                    "Sample ID": "MB-2993",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2994",
                    "Sample ID": "MB-2994",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 254.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2996",
                    "Sample ID": "MB-2996",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 191.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2999",
                    "Sample ID": "MB-2999",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 262,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3001",
                    "Sample ID": "MB-3001",
                    "Nottingham prognostic index": 5.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 263.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3002",
                    "Sample ID": "MB-3002",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.32,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 140.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3005",
                    "Sample ID": "MB-3005",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 45.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 253.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3006",
                    "Sample ID": "MB-3006",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3007",
                    "Sample ID": "MB-3007",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3008",
                    "Sample ID": "MB-3008",
                    "Nottingham prognostic index": 2.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 51.94,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 149.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3013",
                    "Sample ID": "MB-3013",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 50.37,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 238.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3014",
                    "Sample ID": "MB-3014",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 262.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3016",
                    "Sample ID": "MB-3016",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 258.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3021",
                    "Sample ID": "MB-3021",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.08,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 217.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 22,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3025",
                    "Sample ID": "MB-3025",
                    "Nottingham prognostic index": 5.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 256,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3026",
                    "Sample ID": "MB-3026",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 261.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3028",
                    "Sample ID": "MB-3028",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3031",
                    "Sample ID": "MB-3031",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.76,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 35.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3032",
                    "Sample ID": "MB-3032",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 50.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 250.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3033",
                    "Sample ID": "MB-3033",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3035",
                    "Sample ID": "MB-3035",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 260.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3037",
                    "Sample ID": "MB-3037",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.19,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 98.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3046",
                    "Sample ID": "MB-3046",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 73.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3049",
                    "Sample ID": "MB-3049",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.17,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 259.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3050",
                    "Sample ID": "MB-3050",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 255.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3057",
                    "Sample ID": "MB-3057",
                    "Nottingham prognostic index": 5.086,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 43,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3058",
                    "Sample ID": "MB-3058",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 254.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3060",
                    "Sample ID": "MB-3060",
                    "Nottingham prognostic index": 5.072,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 36,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3062",
                    "Sample ID": "MB-3062",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3063",
                    "Sample ID": "MB-3063",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 28.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3064",
                    "Sample ID": "MB-3064",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 46.7,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 165.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3067",
                    "Sample ID": "MB-3067",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.29,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 259.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3079",
                    "Sample ID": "MB-3079",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.54,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 149.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0442",
                    "Sample ID": "MB-0442",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 103.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3085",
                    "Sample ID": "MB-3085",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.68,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 210.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3092",
                    "Sample ID": "MB-3092",
                    "Nottingham prognostic index": 5.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.73,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 152.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 38,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3102",
                    "Sample ID": "MB-3102",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 258.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3103",
                    "Sample ID": "MB-3103",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 28.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3104",
                    "Sample ID": "MB-3104",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 28.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3105",
                    "Sample ID": "MB-3105",
                    "Nottingham prognostic index": 3.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 48.34,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 252.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3110",
                    "Sample ID": "MB-3110",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.07,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 100.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3121",
                    "Sample ID": "MB-3121",
                    "Nottingham prognostic index": 2.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3122",
                    "Sample ID": "MB-3122",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 257.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3123",
                    "Sample ID": "MB-3123",
                    "Nottingham prognostic index": 6.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 167.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3153",
                    "Sample ID": "MB-3153",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 227.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3165",
                    "Sample ID": "MB-3165",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 221.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3167",
                    "Sample ID": "MB-3167",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 136.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3171",
                    "Sample ID": "MB-3171",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 219.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3181",
                    "Sample ID": "MB-3181",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.6,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 178.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3211",
                    "Sample ID": "MB-3211",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 145.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3218",
                    "Sample ID": "MB-3218",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 248.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3222",
                    "Sample ID": "MB-3222",
                    "Nottingham prognostic index": 2.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.03,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 23.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3228",
                    "Sample ID": "MB-3228",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.31,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 252,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3235",
                    "Sample ID": "MB-3235",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 236.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3252",
                    "Sample ID": "MB-3252",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 41.4,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 99.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3253",
                    "Sample ID": "MB-3253",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3254",
                    "Sample ID": "MB-3254",
                    "Nottingham prognostic index": 2.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 50.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3266",
                    "Sample ID": "MB-3266",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3271",
                    "Sample ID": "MB-3271",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3272",
                    "Sample ID": "MB-3272",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3275",
                    "Sample ID": "MB-3275",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 41.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3277",
                    "Sample ID": "MB-3277",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 29.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3292",
                    "Sample ID": "MB-3292",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.04,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 217.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3295",
                    "Sample ID": "MB-3295",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 158.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3297",
                    "Sample ID": "MB-3297",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 236.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3300",
                    "Sample ID": "MB-3300",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 247,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3301",
                    "Sample ID": "MB-3301",
                    "Nottingham prognostic index": 3.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 248.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 32,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3303",
                    "Sample ID": "MB-3303",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.96,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 243.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3328",
                    "Sample ID": "MB-3328",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.65,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 191.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3329",
                    "Sample ID": "MB-3329",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3341",
                    "Sample ID": "MB-3341",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 148.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3344",
                    "Sample ID": "MB-3344",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 33.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 241.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3350",
                    "Sample ID": "MB-3350",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 227.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3351",
                    "Sample ID": "MB-3351",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 39.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 241.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3355",
                    "Sample ID": "MB-3355",
                    "Nottingham prognostic index": 6.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 109,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3357",
                    "Sample ID": "MB-3357",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3360",
                    "Sample ID": "MB-3360",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 26.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3361",
                    "Sample ID": "MB-3361",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 68.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4908",
                    "Sample ID": "MB-4908",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 47.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4911",
                    "Sample ID": "MB-4911",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4912",
                    "Sample ID": "MB-4912",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3371",
                    "Sample ID": "MB-3371",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 241.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4928",
                    "Sample ID": "MB-4928",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 220.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4929",
                    "Sample ID": "MB-4929",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.49,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 40,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4930",
                    "Sample ID": "MB-4930",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 58.43333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3382",
                    "Sample ID": "MB-3382",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 136.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4933",
                    "Sample ID": "MB-4933",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 272.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4934",
                    "Sample ID": "MB-4934",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4935",
                    "Sample ID": "MB-4935",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3389",
                    "Sample ID": "MB-3389",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 240.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4938",
                    "Sample ID": "MB-4938",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 33.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4941",
                    "Sample ID": "MB-4941",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 58.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4942",
                    "Sample ID": "MB-4942",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.31,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 124.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4944",
                    "Sample ID": "MB-4944",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 237.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4945",
                    "Sample ID": "MB-4945",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 20.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4949",
                    "Sample ID": "MB-4949",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 216.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4950",
                    "Sample ID": "MB-4950",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3430",
                    "Sample ID": "MB-3430",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 219.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3435",
                    "Sample ID": "MB-3435",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 25.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3436",
                    "Sample ID": "MB-3436",
                    "Nottingham prognostic index": 6.26,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 130,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0524",
                    "Sample ID": "MB-0524",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3439",
                    "Sample ID": "MB-3439",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.67,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 188.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3450",
                    "Sample ID": "MB-3450",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 240.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3452",
                    "Sample ID": "MB-3452",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3453",
                    "Sample ID": "MB-3453",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3459",
                    "Sample ID": "MB-3459",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 241.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4968",
                    "Sample ID": "MB-4968",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.03,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 78.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3466",
                    "Sample ID": "MB-3466",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 234.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3467",
                    "Sample ID": "MB-3467",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 21.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4974",
                    "Sample ID": "MB-4974",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 176.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4976",
                    "Sample ID": "MB-4976",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 73.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 224.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4977",
                    "Sample ID": "MB-4977",
                    "Nottingham prognostic index": 6.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 216.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4978",
                    "Sample ID": "MB-4978",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 58.89,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 198.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3488",
                    "Sample ID": "MB-3488",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4982",
                    "Sample ID": "MB-4982",
                    "Nottingham prognostic index": 6.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3492",
                    "Sample ID": "MB-3492",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0542",
                    "Sample ID": "MB-0542",
                    "Nottingham prognostic index": 6.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4991",
                    "Sample ID": "MB-4991",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 126.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3502",
                    "Sample ID": "MB-3502",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 229.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3506",
                    "Sample ID": "MB-3506",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.28,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 240.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3510",
                    "Sample ID": "MB-3510",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 67.6,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 59.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0549",
                    "Sample ID": "MB-0549",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.84,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 25.96666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3526",
                    "Sample ID": "MB-3526",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3528",
                    "Sample ID": "MB-3528",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 113.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3530",
                    "Sample ID": "MB-3530",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.94,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 112.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3536",
                    "Sample ID": "MB-3536",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "UNDEF",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3545",
                    "Sample ID": "MB-3545",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 232.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0558",
                    "Sample ID": "MB-0558",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 97.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3548",
                    "Sample ID": "MB-3548",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 234.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5014",
                    "Sample ID": "MB-5014",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 213.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5015",
                    "Sample ID": "MB-5015",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 252.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0569",
                    "Sample ID": "MB-0569",
                    "Nottingham prognostic index": 6.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 59.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3582",
                    "Sample ID": "MB-3582",
                    "Nottingham prognostic index": 1.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 63.97,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 229.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "",
                    "Tumor Size": 60,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3600",
                    "Sample ID": "MB-3600",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 214.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3606",
                    "Sample ID": "MB-3606",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5022",
                    "Sample ID": "MB-5022",
                    "Nottingham prognostic index": 5.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.71,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 118.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5027",
                    "Sample ID": "MB-5027",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 189.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5033",
                    "Sample ID": "MB-5033",
                    "Nottingham prognostic index": 2.086,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.92,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 52.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 43,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5035",
                    "Sample ID": "MB-5035",
                    "Nottingham prognostic index": 4.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.47,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 213.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 55,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5039",
                    "Sample ID": "MB-5039",
                    "Nottingham prognostic index": 5.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5040",
                    "Sample ID": "MB-5040",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5041",
                    "Sample ID": "MB-5041",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 173.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5043",
                    "Sample ID": "MB-5043",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5044",
                    "Sample ID": "MB-5044",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5045",
                    "Sample ID": "MB-5045",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 168.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5048",
                    "Sample ID": "MB-5048",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5049",
                    "Sample ID": "MB-5049",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 255.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5050",
                    "Sample ID": "MB-5050",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5052",
                    "Sample ID": "MB-5052",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5053",
                    "Sample ID": "MB-5053",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5054",
                    "Sample ID": "MB-5054",
                    "Nottingham prognostic index": 4.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5057",
                    "Sample ID": "MB-5057",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 56.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5058",
                    "Sample ID": "MB-5058",
                    "Nottingham prognostic index": 6.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 178.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5059",
                    "Sample ID": "MB-5059",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 257.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3866",
                    "Sample ID": "MB-3866",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 225.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5061",
                    "Sample ID": "MB-5061",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.43333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5062",
                    "Sample ID": "MB-5062",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 168.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5063",
                    "Sample ID": "MB-5063",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 215.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5064",
                    "Sample ID": "MB-5064",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5065",
                    "Sample ID": "MB-5065",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5066",
                    "Sample ID": "MB-5066",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 94.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4004",
                    "Sample ID": "MB-4004",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 256.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5070",
                    "Sample ID": "MB-5070",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 213.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5072",
                    "Sample ID": "MB-5072",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5073",
                    "Sample ID": "MB-5073",
                    "Nottingham prognostic index": 3.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 67.87,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 194.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5074",
                    "Sample ID": "MB-5074",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.59,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 221.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5076",
                    "Sample ID": "MB-5076",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 28.05,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 26.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5078",
                    "Sample ID": "MB-5078",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 87.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5079",
                    "Sample ID": "MB-5079",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5081",
                    "Sample ID": "MB-5081",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 58,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5084",
                    "Sample ID": "MB-5084",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 198.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5086",
                    "Sample ID": "MB-5086",
                    "Nottingham prognostic index": 2.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 65.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5088",
                    "Sample ID": "MB-5088",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4059",
                    "Sample ID": "MB-4059",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 172,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4079",
                    "Sample ID": "MB-4079",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 351,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5097",
                    "Sample ID": "MB-5097",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5098",
                    "Sample ID": "MB-5098",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 61.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 186.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4119",
                    "Sample ID": "MB-4119",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 67.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5101",
                    "Sample ID": "MB-5101",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5102",
                    "Sample ID": "MB-5102",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5104",
                    "Sample ID": "MB-5104",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.81,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 122.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5105",
                    "Sample ID": "MB-5105",
                    "Nottingham prognostic index": 3.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 204.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5106",
                    "Sample ID": "MB-5106",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 190.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5107",
                    "Sample ID": "MB-5107",
                    "Nottingham prognostic index": 4.082,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.06,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 82.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 41,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5109",
                    "Sample ID": "MB-5109",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.94,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 125.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5110",
                    "Sample ID": "MB-5110",
                    "Nottingham prognostic index": 1.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 59.12,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 21.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5113",
                    "Sample ID": "MB-5113",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5114",
                    "Sample ID": "MB-5114",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5115",
                    "Sample ID": "MB-5115",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 77.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5116",
                    "Sample ID": "MB-5116",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5117",
                    "Sample ID": "MB-5117",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 209.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5118",
                    "Sample ID": "MB-5118",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5119",
                    "Sample ID": "MB-5119",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 59.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5120",
                    "Sample ID": "MB-5120",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5121",
                    "Sample ID": "MB-5121",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.02,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 114.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5122",
                    "Sample ID": "MB-5122",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 77.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5123",
                    "Sample ID": "MB-5123",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5124",
                    "Sample ID": "MB-5124",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 83.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5126",
                    "Sample ID": "MB-5126",
                    "Nottingham prognostic index": 5.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-5127",
                    "Sample ID": "MB-5127",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "UNDEF",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 191.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5130",
                    "Sample ID": "MB-5130",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 255,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5131",
                    "Sample ID": "MB-5131",
                    "Nottingham prognostic index": 4.006,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.08,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 264.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5134",
                    "Sample ID": "MB-5134",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 196.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5135",
                    "Sample ID": "MB-5135",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5136",
                    "Sample ID": "MB-5136",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.22,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 178.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5137",
                    "Sample ID": "MB-5137",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.04,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 43.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5138",
                    "Sample ID": "MB-5138",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-5139",
                    "Sample ID": "MB-5139",
                    "Nottingham prognostic index": 6.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5140",
                    "Sample ID": "MB-5140",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.31,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 134.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5143",
                    "Sample ID": "MB-5143",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 127.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5144",
                    "Sample ID": "MB-5144",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 213.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5145",
                    "Sample ID": "MB-5145",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 159.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4292",
                    "Sample ID": "MB-4292",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 335.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4293",
                    "Sample ID": "MB-4293",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 219.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4298",
                    "Sample ID": "MB-4298",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.24,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 55.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4300",
                    "Sample ID": "MB-4300",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 189.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5154",
                    "Sample ID": "MB-5154",
                    "Nottingham prognostic index": 4.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 31.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4306",
                    "Sample ID": "MB-4306",
                    "Nottingham prognostic index": 2.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 69.19,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 234.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5157",
                    "Sample ID": "MB-5157",
                    "Nottingham prognostic index": 6.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 18.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5158",
                    "Sample ID": "MB-5158",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.53,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 244.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4317",
                    "Sample ID": "MB-4317",
                    "Nottingham prognostic index": 3.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 177.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5161",
                    "Sample ID": "MB-5161",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5162",
                    "Sample ID": "MB-5162",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.38,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 164.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4323",
                    "Sample ID": "MB-4323",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 80.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 126.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4324",
                    "Sample ID": "MB-4324",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 87.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5166",
                    "Sample ID": "MB-5166",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4329",
                    "Sample ID": "MB-4329",
                    "Nottingham prognostic index": 5.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 168.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5169",
                    "Sample ID": "MB-5169",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5171",
                    "Sample ID": "MB-5171",
                    "Nottingham prognostic index": 3.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4333",
                    "Sample ID": "MB-4333",
                    "Nottingham prognostic index": 2.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 64.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 207.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5173",
                    "Sample ID": "MB-5173",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5174",
                    "Sample ID": "MB-5174",
                    "Nottingham prognostic index": 1.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 54.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 151.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5175",
                    "Sample ID": "MB-5175",
                    "Nottingham prognostic index": 2.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 50.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5176",
                    "Sample ID": "MB-5176",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 112.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4348",
                    "Sample ID": "MB-4348",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 226.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4350",
                    "Sample ID": "MB-4350",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4351",
                    "Sample ID": "MB-4351",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 68.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4353",
                    "Sample ID": "MB-4353",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4354",
                    "Sample ID": "MB-4354",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4357",
                    "Sample ID": "MB-4357",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4360",
                    "Sample ID": "MB-4360",
                    "Nottingham prognostic index": 4.016,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 11.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 8,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2614",
                    "Sample ID": "MB-2614",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 43.72,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 64.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4368",
                    "Sample ID": "MB-4368",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4374",
                    "Sample ID": "MB-4374",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4375",
                    "Sample ID": "MB-4375",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 291.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2624",
                    "Sample ID": "MB-2624",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 53.53,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 128.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4390",
                    "Sample ID": "MB-4390",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4395",
                    "Sample ID": "MB-4395",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4407",
                    "Sample ID": "MB-4407",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 83.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4408",
                    "Sample ID": "MB-4408",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 206.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2642",
                    "Sample ID": "MB-2642",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 30.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4417",
                    "Sample ID": "MB-4417",
                    "Nottingham prognostic index": 4.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4418",
                    "Sample ID": "MB-4418",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 307.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2669",
                    "Sample ID": "MB-2669",
                    "Nottingham prognostic index": 3.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.56,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 73.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 24,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4426",
                    "Sample ID": "MB-4426",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4434",
                    "Sample ID": "MB-4434",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 148.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4442",
                    "Sample ID": "MB-4442",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 296.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4484",
                    "Sample ID": "MB-4484",
                    "Nottingham prognostic index": 4.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.23,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 52.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 55,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4529",
                    "Sample ID": "MB-4529",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 126.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4548",
                    "Sample ID": "MB-4548",
                    "Nottingham prognostic index": 5.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 322.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4557",
                    "Sample ID": "MB-4557",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 51.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 279.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2724",
                    "Sample ID": "MB-2724",
                    "Nottingham prognostic index": 4.016,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 8,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4578",
                    "Sample ID": "MB-4578",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 197.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4591",
                    "Sample ID": "MB-4591",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 41.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4593",
                    "Sample ID": "MB-4593",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2735",
                    "Sample ID": "MB-2735",
                    "Nottingham prognostic index": 5.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 274.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4599",
                    "Sample ID": "MB-4599",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 191.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4601",
                    "Sample ID": "MB-4601",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 56.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4602",
                    "Sample ID": "MB-4602",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2747",
                    "Sample ID": "MB-2747",
                    "Nottingham prognostic index": 2.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 68.23,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 234.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4607",
                    "Sample ID": "MB-4607",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 121.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4616",
                    "Sample ID": "MB-4616",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4618",
                    "Sample ID": "MB-4618",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 267.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4621",
                    "Sample ID": "MB-4621",
                    "Nottingham prognostic index": 6.106,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 271.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 53,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4622",
                    "Sample ID": "MB-4622",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 282.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4623",
                    "Sample ID": "MB-4623",
                    "Nottingham prognostic index": 5.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 292.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2760",
                    "Sample ID": "MB-2760",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4627",
                    "Sample ID": "MB-4627",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.65,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 186.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4630",
                    "Sample ID": "MB-4630",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 67.48,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 95.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4633",
                    "Sample ID": "MB-4633",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 318.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4634",
                    "Sample ID": "MB-4634",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 109.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2769",
                    "Sample ID": "MB-2769",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.9,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 160,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4640",
                    "Sample ID": "MB-4640",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4641",
                    "Sample ID": "MB-4641",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 148.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4642",
                    "Sample ID": "MB-4642",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 285.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2774",
                    "Sample ID": "MB-2774",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.06,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 131.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 35,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4644",
                    "Sample ID": "MB-4644",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2779",
                    "Sample ID": "MB-2779",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 36.8,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 275.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4649",
                    "Sample ID": "MB-4649",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4651",
                    "Sample ID": "MB-4651",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4653",
                    "Sample ID": "MB-4653",
                    "Nottingham prognostic index": 4.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2791",
                    "Sample ID": "MB-2791",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 271.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4655",
                    "Sample ID": "MB-4655",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 99,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2793",
                    "Sample ID": "MB-2793",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 267.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2795",
                    "Sample ID": "MB-2795",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 272.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2796",
                    "Sample ID": "MB-2796",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.94,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 87.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2797",
                    "Sample ID": "MB-2797",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 50.07,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 252.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2801",
                    "Sample ID": "MB-2801",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.35,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 271.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 13,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2803",
                    "Sample ID": "MB-2803",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4669",
                    "Sample ID": "MB-4669",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2815",
                    "Sample ID": "MB-2815",
                    "Nottingham prognostic index": 2.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 64.25,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 257.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 22,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2819",
                    "Sample ID": "MB-2819",
                    "Nottingham prognostic index": 2.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.95,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 270.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2820",
                    "Sample ID": "MB-2820",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 254.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2821",
                    "Sample ID": "MB-2821",
                    "Nottingham prognostic index": 1.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 57.39,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 136.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2823",
                    "Sample ID": "MB-2823",
                    "Nottingham prognostic index": 4.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.97,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 269.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2827",
                    "Sample ID": "MB-2827",
                    "Nottingham prognostic index": 5.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 235.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2833",
                    "Sample ID": "MB-2833",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 259.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2834",
                    "Sample ID": "MB-2834",
                    "Nottingham prognostic index": 4.018,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 153.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 9,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4682",
                    "Sample ID": "MB-4682",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2838",
                    "Sample ID": "MB-2838",
                    "Nottingham prognostic index": 3.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.12,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 270.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2840",
                    "Sample ID": "MB-2840",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.48,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 269,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4687",
                    "Sample ID": "MB-4687",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 81.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 74.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2843",
                    "Sample ID": "MB-2843",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 231.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2844",
                    "Sample ID": "MB-2844",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4692",
                    "Sample ID": "MB-4692",
                    "Nottingham prognostic index": 2.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.49,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 107.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2846",
                    "Sample ID": "MB-2846",
                    "Nottingham prognostic index": 3.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 5,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4695",
                    "Sample ID": "MB-4695",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.12,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 21.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2848",
                    "Sample ID": "MB-2848",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.11,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 227.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2849",
                    "Sample ID": "MB-2849",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2850",
                    "Sample ID": "MB-2850",
                    "Nottingham prognostic index": 6.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 31.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 9.433333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2851",
                    "Sample ID": "MB-2851",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 159,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4702",
                    "Sample ID": "MB-4702",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 300.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2854",
                    "Sample ID": "MB-2854",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.53,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 270.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 22,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4705",
                    "Sample ID": "MB-4705",
                    "Nottingham prognostic index": 3.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 213.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2858",
                    "Sample ID": "MB-2858",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.94,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 141.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "MIXED NST AND A SPECIAL TYPE",
                    "Tumor Size": 26,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2863",
                    "Sample ID": "MB-2863",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.58,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 258.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "MIXED NST AND A SPECIAL TYPE",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2867",
                    "Sample ID": "MB-2867",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 47.1,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 269.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4709",
                    "Sample ID": "MB-4709",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4710",
                    "Sample ID": "MB-4710",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.66666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4711",
                    "Sample ID": "MB-4711",
                    "Nottingham prognostic index": 6.198,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 99,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4712",
                    "Sample ID": "MB-4712",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 249.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4714",
                    "Sample ID": "MB-4714",
                    "Nottingham prognostic index": 6.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 83.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4715",
                    "Sample ID": "MB-4715",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4716",
                    "Sample ID": "MB-4716",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.98,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 76.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4717",
                    "Sample ID": "MB-4717",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4718",
                    "Sample ID": "MB-4718",
                    "Nottingham prognostic index": 2.198,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 44.27,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 198.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 99,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4719",
                    "Sample ID": "MB-4719",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4721",
                    "Sample ID": "MB-4721",
                    "Nottingham prognostic index": 4.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 66.39,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 23.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4722",
                    "Sample ID": "MB-4722",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 64.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4723",
                    "Sample ID": "MB-4723",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4724",
                    "Sample ID": "MB-4724",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4725",
                    "Sample ID": "MB-4725",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4729",
                    "Sample ID": "MB-4729",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 28,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4730",
                    "Sample ID": "MB-4730",
                    "Nottingham prognostic index": 4.136,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 68,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4731",
                    "Sample ID": "MB-4731",
                    "Nottingham prognostic index": 5.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4732",
                    "Sample ID": "MB-4732",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 26.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4733",
                    "Sample ID": "MB-4733",
                    "Nottingham prognostic index": 6.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-2952",
                    "Sample ID": "MB-2952",
                    "Nottingham prognostic index": 2.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 52.67,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 189.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4737",
                    "Sample ID": "MB-4737",
                    "Nottingham prognostic index": 5.092,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 46,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4738",
                    "Sample ID": "MB-4738",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.27,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 176.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4739",
                    "Sample ID": "MB-4739",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 161.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4741",
                    "Sample ID": "MB-4741",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.02,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 56.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-2963",
                    "Sample ID": "MB-2963",
                    "Nottingham prognostic index": 5.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.99,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 227.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 10,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4743",
                    "Sample ID": "MB-4743",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.61,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 230.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4744",
                    "Sample ID": "MB-4744",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 153,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4745",
                    "Sample ID": "MB-4745",
                    "Nottingham prognostic index": 5.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 37,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4746",
                    "Sample ID": "MB-4746",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 244.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4749",
                    "Sample ID": "MB-4749",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4750",
                    "Sample ID": "MB-4750",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4752",
                    "Sample ID": "MB-4752",
                    "Nottingham prognostic index": 4.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4757",
                    "Sample ID": "MB-4757",
                    "Nottingham prognostic index": 5.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4758",
                    "Sample ID": "MB-4758",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4760",
                    "Sample ID": "MB-4760",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 48.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4762",
                    "Sample ID": "MB-4762",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.82,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 252.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4763",
                    "Sample ID": "MB-4763",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4764",
                    "Sample ID": "MB-4764",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.95,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 245.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4767",
                    "Sample ID": "MB-4767",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 47.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4769",
                    "Sample ID": "MB-4769",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4770",
                    "Sample ID": "MB-4770",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 152.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4771",
                    "Sample ID": "MB-4771",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 297.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4778",
                    "Sample ID": "MB-4778",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.62,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 206.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4779",
                    "Sample ID": "MB-4779",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4782",
                    "Sample ID": "MB-4782",
                    "Nottingham prognostic index": 5,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.85,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 251.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4784",
                    "Sample ID": "MB-4784",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 145.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4785",
                    "Sample ID": "MB-4785",
                    "Nottingham prognostic index": 3.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 121.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4787",
                    "Sample ID": "MB-4787",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4790",
                    "Sample ID": "MB-4790",
                    "Nottingham prognostic index": 3.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4791",
                    "Sample ID": "MB-4791",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 83.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 173.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4792",
                    "Sample ID": "MB-4792",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 40.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4793",
                    "Sample ID": "MB-4793",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 83.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4794",
                    "Sample ID": "MB-4794",
                    "Nottingham prognostic index": 2.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4796",
                    "Sample ID": "MB-4796",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4797",
                    "Sample ID": "MB-4797",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.06,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 99.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4798",
                    "Sample ID": "MB-4798",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 257.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4800",
                    "Sample ID": "MB-4800",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4801",
                    "Sample ID": "MB-4801",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 130.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4802",
                    "Sample ID": "MB-4802",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.67,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 43.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4805",
                    "Sample ID": "MB-4805",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 129.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4806",
                    "Sample ID": "MB-4806",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 201.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4809",
                    "Sample ID": "MB-4809",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 286.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4814",
                    "Sample ID": "MB-4814",
                    "Nottingham prognostic index": 3.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 39.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 73.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4818",
                    "Sample ID": "MB-4818",
                    "Nottingham prognostic index": 4.114,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 76.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 57,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4820",
                    "Sample ID": "MB-4820",
                    "Nottingham prognostic index": 2.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 67.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-4822",
                    "Sample ID": "MB-4822",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4823",
                    "Sample ID": "MB-4823",
                    "Nottingham prognostic index": 3.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.15,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 282.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3083",
                    "Sample ID": "MB-3083",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4827",
                    "Sample ID": "MB-4827",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3088",
                    "Sample ID": "MB-3088",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 256.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4829",
                    "Sample ID": "MB-4829",
                    "Nottingham prognostic index": 2.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 83.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 176.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4832",
                    "Sample ID": "MB-4832",
                    "Nottingham prognostic index": 2.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 45.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 141.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4834",
                    "Sample ID": "MB-4834",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4836",
                    "Sample ID": "MB-4836",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4838",
                    "Sample ID": "MB-4838",
                    "Nottingham prognostic index": 3.198,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 99,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4839",
                    "Sample ID": "MB-4839",
                    "Nottingham prognostic index": 1.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 67.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 299.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4843",
                    "Sample ID": "MB-4843",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 54.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 265.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4845",
                    "Sample ID": "MB-4845",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 86.75,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 25.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4846",
                    "Sample ID": "MB-4846",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4849",
                    "Sample ID": "MB-4849",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 81.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4851",
                    "Sample ID": "MB-4851",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4853",
                    "Sample ID": "MB-4853",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 62.35,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 265.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4855",
                    "Sample ID": "MB-4855",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 41.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4858",
                    "Sample ID": "MB-4858",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 129.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4859",
                    "Sample ID": "MB-4859",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 157.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4860",
                    "Sample ID": "MB-4860",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.95,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 234.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4862",
                    "Sample ID": "MB-4862",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4865",
                    "Sample ID": "MB-4865",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 229.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4866",
                    "Sample ID": "MB-4866",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 43.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 224.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4867",
                    "Sample ID": "MB-4867",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 221.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4869",
                    "Sample ID": "MB-4869",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 29.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4870",
                    "Sample ID": "MB-4870",
                    "Nottingham prognostic index": 2.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 57.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 229.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4871",
                    "Sample ID": "MB-4871",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4872",
                    "Sample ID": "MB-4872",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 157.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4873",
                    "Sample ID": "MB-4873",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4876",
                    "Sample ID": "MB-4876",
                    "Nottingham prognostic index": 3.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4878",
                    "Sample ID": "MB-4878",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4879",
                    "Sample ID": "MB-4879",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4880",
                    "Sample ID": "MB-4880",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.68,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 210.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4881",
                    "Sample ID": "MB-4881",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 274.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3298",
                    "Sample ID": "MB-3298",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.75,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 242.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4883",
                    "Sample ID": "MB-4883",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 268.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4886",
                    "Sample ID": "MB-4886",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4887",
                    "Sample ID": "MB-4887",
                    "Nottingham prognostic index": 5.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 33,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4888",
                    "Sample ID": "MB-4888",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 230.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4893",
                    "Sample ID": "MB-4893",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 176.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4894",
                    "Sample ID": "MB-4894",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 232.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4896",
                    "Sample ID": "MB-4896",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4897",
                    "Sample ID": "MB-4897",
                    "Nottingham prognostic index": 2.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 40.04,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 197.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4898",
                    "Sample ID": "MB-4898",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4899",
                    "Sample ID": "MB-4899",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 275.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4900",
                    "Sample ID": "MB-4900",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 224.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4904",
                    "Sample ID": "MB-4904",
                    "Nottingham prognostic index": 5,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 129.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-4906",
                    "Sample ID": "MB-4906",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 73.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 233.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5475",
                    "Sample ID": "MB-5475",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 2.533333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5477",
                    "Sample ID": "MB-5477",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5478",
                    "Sample ID": "MB-5478",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4925",
                    "Sample ID": "MB-4925",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5482",
                    "Sample ID": "MB-5482",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 17.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5483",
                    "Sample ID": "MB-5483",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5484",
                    "Sample ID": "MB-5484",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.3,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 238.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4931",
                    "Sample ID": "MB-4931",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5486",
                    "Sample ID": "MB-5486",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5489",
                    "Sample ID": "MB-5489",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 216.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5490",
                    "Sample ID": "MB-5490",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4937",
                    "Sample ID": "MB-4937",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 77.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5492",
                    "Sample ID": "MB-5492",
                    "Nottingham prognostic index": 6.102,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.28,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 23.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 51,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5493",
                    "Sample ID": "MB-5493",
                    "Nottingham prognostic index": 4.102,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 51,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5495",
                    "Sample ID": "MB-5495",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5497",
                    "Sample ID": "MB-5497",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 237.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5498",
                    "Sample ID": "MB-5498",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 225.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5499",
                    "Sample ID": "MB-5499",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 65.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 123.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5502",
                    "Sample ID": "MB-5502",
                    "Nottingham prognostic index": 3.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 189.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4952",
                    "Sample ID": "MB-4952",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4956",
                    "Sample ID": "MB-4956",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 69.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4957",
                    "Sample ID": "MB-4957",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 197.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3437",
                    "Sample ID": "MB-3437",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4961",
                    "Sample ID": "MB-4961",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 219.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4962",
                    "Sample ID": "MB-4962",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 197.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4965",
                    "Sample ID": "MB-4965",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 263.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4966",
                    "Sample ID": "MB-4966",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 55.83,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 49.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4967",
                    "Sample ID": "MB-4967",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 130.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5525",
                    "Sample ID": "MB-5525",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4969",
                    "Sample ID": "MB-4969",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 198.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4970",
                    "Sample ID": "MB-4970",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5529",
                    "Sample ID": "MB-5529",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5530",
                    "Sample ID": "MB-5530",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5531",
                    "Sample ID": "MB-5531",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 183.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5532",
                    "Sample ID": "MB-5532",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4981",
                    "Sample ID": "MB-4981",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 180.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5534",
                    "Sample ID": "MB-5534",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4986",
                    "Sample ID": "MB-4986",
                    "Nottingham prognostic index": 3.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3497",
                    "Sample ID": "MB-3497",
                    "Nottingham prognostic index": 6.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 2,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5541",
                    "Sample ID": "MB-5541",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4992",
                    "Sample ID": "MB-4992",
                    "Nottingham prognostic index": 3.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.47,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 165.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 33,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4993",
                    "Sample ID": "MB-4993",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4994",
                    "Sample ID": "MB-4994",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3525",
                    "Sample ID": "MB-3525",
                    "Nottingham prognostic index": 6.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 236.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4998",
                    "Sample ID": "MB-4998",
                    "Nottingham prognostic index": 6.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.27,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 65.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4999",
                    "Sample ID": "MB-4999",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5001",
                    "Sample ID": "MB-5001",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5004",
                    "Sample ID": "MB-5004",
                    "Nottingham prognostic index": 5.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 216.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 37,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5008",
                    "Sample ID": "MB-5008",
                    "Nottingham prognostic index": 5.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 223.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-3547",
                    "Sample ID": "MB-3547",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.13,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 33,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "DCIS",
                    "Tumor Size": 40,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5013",
                    "Sample ID": "MB-5013",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 251.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5558",
                    "Sample ID": "MB-5558",
                    "Nottingham prognostic index": 5.15,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 25.03333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 75,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5559",
                    "Sample ID": "MB-5559",
                    "Nottingham prognostic index": 5.096,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 18.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 48,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-3576",
                    "Sample ID": "MB-3576",
                    "Nottingham prognostic index": 4.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 2,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.04,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 24.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 37,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5018",
                    "Sample ID": "MB-5018",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5019",
                    "Sample ID": "MB-5019",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5020",
                    "Sample ID": "MB-5020",
                    "Nottingham prognostic index": 6.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5566",
                    "Sample ID": "MB-5566",
                    "Nottingham prognostic index": 6.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 234.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5567",
                    "Sample ID": "MB-5567",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 178.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5571",
                    "Sample ID": "MB-5571",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.84,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 153.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5572",
                    "Sample ID": "MB-5572",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.88,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 178.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5575",
                    "Sample ID": "MB-5575",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5576",
                    "Sample ID": "MB-5576",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5577",
                    "Sample ID": "MB-5577",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.64,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 55.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5579",
                    "Sample ID": "MB-5579",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5580",
                    "Sample ID": "MB-5580",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5582",
                    "Sample ID": "MB-5582",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 222.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5583",
                    "Sample ID": "MB-5583",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5584",
                    "Sample ID": "MB-5584",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5585",
                    "Sample ID": "MB-5585",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.88,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 53.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5588",
                    "Sample ID": "MB-5588",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5589",
                    "Sample ID": "MB-5589",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5590",
                    "Sample ID": "MB-5590",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 17.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5591",
                    "Sample ID": "MB-5591",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 155.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5592",
                    "Sample ID": "MB-5592",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.01,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 26.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5593",
                    "Sample ID": "MB-5593",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 92.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5060",
                    "Sample ID": "MB-5060",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5597",
                    "Sample ID": "MB-5597",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5599",
                    "Sample ID": "MB-5599",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 224.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5601",
                    "Sample ID": "MB-5601",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 214.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5602",
                    "Sample ID": "MB-5602",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 224.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5603",
                    "Sample ID": "MB-5603",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 171.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5604",
                    "Sample ID": "MB-5604",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 145.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5068",
                    "Sample ID": "MB-5068",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5613",
                    "Sample ID": "MB-5613",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 212.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5614",
                    "Sample ID": "MB-5614",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 116.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5616",
                    "Sample ID": "MB-5616",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 180.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5617",
                    "Sample ID": "MB-5617",
                    "Nottingham prognostic index": 4.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5620",
                    "Sample ID": "MB-5620",
                    "Nottingham prognostic index": 4.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5622",
                    "Sample ID": "MB-5622",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5623",
                    "Sample ID": "MB-5623",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 137.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5624",
                    "Sample ID": "MB-5624",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.43,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 136,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5625",
                    "Sample ID": "MB-5625",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.51,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 32.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5626",
                    "Sample ID": "MB-5626",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 82.96666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5628",
                    "Sample ID": "MB-5628",
                    "Nottingham prognostic index": 6,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5092",
                    "Sample ID": "MB-5092",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5093",
                    "Sample ID": "MB-5093",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 142.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5633",
                    "Sample ID": "MB-5633",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5634",
                    "Sample ID": "MB-5634",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 62.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5100",
                    "Sample ID": "MB-5100",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 32.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5636",
                    "Sample ID": "MB-5636",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5638",
                    "Sample ID": "MB-5638",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 195.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5640",
                    "Sample ID": "MB-5640",
                    "Nottingham prognostic index": 3.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 172.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5641",
                    "Sample ID": "MB-5641",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 181.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5642",
                    "Sample ID": "MB-5642",
                    "Nottingham prognostic index": 4.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 156.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5645",
                    "Sample ID": "MB-5645",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5646",
                    "Sample ID": "MB-5646",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 167.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5647",
                    "Sample ID": "MB-5647",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5648",
                    "Sample ID": "MB-5648",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.92,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 199.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5651",
                    "Sample ID": "MB-5651",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5652",
                    "Sample ID": "MB-5652",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5653",
                    "Sample ID": "MB-5653",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5654",
                    "Sample ID": "MB-5654",
                    "Nottingham prognostic index": 4.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 173.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5655",
                    "Sample ID": "MB-5655",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 191.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5656",
                    "Sample ID": "MB-5656",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 126.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6001",
                    "Sample ID": "MB-6001",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.7,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 135.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6006",
                    "Sample ID": "MB-6006",
                    "Nottingham prognostic index": 2.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 86.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 63.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6007",
                    "Sample ID": "MB-6007",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6008",
                    "Sample ID": "MB-6008",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.33,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 69.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6010",
                    "Sample ID": "MB-6010",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.28,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 218.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6011",
                    "Sample ID": "MB-6011",
                    "Nottingham prognostic index": 1.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 59.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6012",
                    "Sample ID": "MB-6012",
                    "Nottingham prognostic index": 3.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 33,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6014",
                    "Sample ID": "MB-6014",
                    "Nottingham prognostic index": 2.114,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 44.48,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 191.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 57,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6016",
                    "Sample ID": "MB-6016",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 87.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 143.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6017",
                    "Sample ID": "MB-6017",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 72.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6018",
                    "Sample ID": "MB-6018",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 143.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6019",
                    "Sample ID": "MB-6019",
                    "Nottingham prognostic index": 3.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 13.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 70,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6020",
                    "Sample ID": "MB-6020",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.63,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 48.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6021",
                    "Sample ID": "MB-6021",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.94,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 301.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6022",
                    "Sample ID": "MB-6022",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 90,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 52.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6023",
                    "Sample ID": "MB-6023",
                    "Nottingham prognostic index": 3.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.28,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 232.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 34,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6024",
                    "Sample ID": "MB-6024",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 252.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6026",
                    "Sample ID": "MB-6026",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 87.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6029",
                    "Sample ID": "MB-6029",
                    "Nottingham prognostic index": 6.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 278.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5147",
                    "Sample ID": "MB-5147",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 20.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5148",
                    "Sample ID": "MB-5148",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 245.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5150",
                    "Sample ID": "MB-5150",
                    "Nottingham prognostic index": 3.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5152",
                    "Sample ID": "MB-5152",
                    "Nottingham prognostic index": 4.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 115.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6044",
                    "Sample ID": "MB-6044",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 219.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5155",
                    "Sample ID": "MB-5155",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 51.08,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 259.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6048",
                    "Sample ID": "MB-6048",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 168.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6049",
                    "Sample ID": "MB-6049",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 264.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5160",
                    "Sample ID": "MB-5160",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 87.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6051",
                    "Sample ID": "MB-6051",
                    "Nottingham prognostic index": 4.072,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.39,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 186.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 36,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6052",
                    "Sample ID": "MB-6052",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.47,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 255.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5163",
                    "Sample ID": "MB-5163",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 212.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5164",
                    "Sample ID": "MB-5164",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6058",
                    "Sample ID": "MB-6058",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 41.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5167",
                    "Sample ID": "MB-5167",
                    "Nottingham prognostic index": 1.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 60.46,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 208.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6060",
                    "Sample ID": "MB-6060",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6062",
                    "Sample ID": "MB-6062",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 31.6,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 282.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5172",
                    "Sample ID": "MB-5172",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6065",
                    "Sample ID": "MB-6065",
                    "Nottingham prognostic index": 3.096,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.69,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 188.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 48,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6068",
                    "Sample ID": "MB-6068",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6069",
                    "Sample ID": "MB-6069",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 258.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6071",
                    "Sample ID": "MB-6071",
                    "Nottingham prognostic index": 5.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5177",
                    "Sample ID": "MB-5177",
                    "Nottingham prognostic index": 5,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-5178",
                    "Sample ID": "MB-5178",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5179",
                    "Sample ID": "MB-5179",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 246.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5182",
                    "Sample ID": "MB-5182",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 134.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5183",
                    "Sample ID": "MB-5183",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5184",
                    "Sample ID": "MB-5184",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.76,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 89.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5185",
                    "Sample ID": "MB-5185",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 77.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4362",
                    "Sample ID": "MB-4362",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 267.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5188",
                    "Sample ID": "MB-5188",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5189",
                    "Sample ID": "MB-5189",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5190",
                    "Sample ID": "MB-5190",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 242.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4381",
                    "Sample ID": "MB-4381",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5193",
                    "Sample ID": "MB-5193",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 88.8,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 54.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5195",
                    "Sample ID": "MB-5195",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 196.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5196",
                    "Sample ID": "MB-5196",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 94.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5197",
                    "Sample ID": "MB-5197",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 223.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4416",
                    "Sample ID": "MB-4416",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.89,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 241.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5200",
                    "Sample ID": "MB-5200",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 52.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5201",
                    "Sample ID": "MB-5201",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 96.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4421",
                    "Sample ID": "MB-4421",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 264.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5205",
                    "Sample ID": "MB-5205",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5206",
                    "Sample ID": "MB-5206",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.45,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 205.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5208",
                    "Sample ID": "MB-5208",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 151.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5209",
                    "Sample ID": "MB-5209",
                    "Nottingham prognostic index": 4.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5211",
                    "Sample ID": "MB-5211",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 247.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5212",
                    "Sample ID": "MB-5212",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 179.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5213",
                    "Sample ID": "MB-5213",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4564",
                    "Sample ID": "MB-4564",
                    "Nottingham prognostic index": 6.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 210.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5215",
                    "Sample ID": "MB-5215",
                    "Nottingham prognostic index": 6.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5218",
                    "Sample ID": "MB-5218",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 254.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5219",
                    "Sample ID": "MB-5219",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.77,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 252.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4598",
                    "Sample ID": "MB-4598",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5222",
                    "Sample ID": "MB-5222",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5223",
                    "Sample ID": "MB-5223",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5224",
                    "Sample ID": "MB-5224",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 90.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 99.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4603",
                    "Sample ID": "MB-4603",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 42.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 239.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5226",
                    "Sample ID": "MB-5226",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5227",
                    "Sample ID": "MB-5227",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5228",
                    "Sample ID": "MB-5228",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 180.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5229",
                    "Sample ID": "MB-5229",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 33.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5230",
                    "Sample ID": "MB-5230",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.17,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 176.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5231",
                    "Sample ID": "MB-5231",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 61.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4626",
                    "Sample ID": "MB-4626",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 143,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5233",
                    "Sample ID": "MB-5233",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 209.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5235",
                    "Sample ID": "MB-5235",
                    "Nottingham prognostic index": 3.012,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 204.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 6,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5236",
                    "Sample ID": "MB-5236",
                    "Nottingham prognostic index": 5.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 166.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 65,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5238",
                    "Sample ID": "MB-5238",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4639",
                    "Sample ID": "MB-4639",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5240",
                    "Sample ID": "MB-5240",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 103.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5243",
                    "Sample ID": "MB-5243",
                    "Nottingham prognostic index": 3.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 62.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5244",
                    "Sample ID": "MB-5244",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 216.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4643",
                    "Sample ID": "MB-4643",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.21,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 41.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5253",
                    "Sample ID": "MB-5253",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.59,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 102.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4648",
                    "Sample ID": "MB-4648",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 168.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5256",
                    "Sample ID": "MB-5256",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5258",
                    "Sample ID": "MB-5258",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5259",
                    "Sample ID": "MB-5259",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 46.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4654",
                    "Sample ID": "MB-4654",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5261",
                    "Sample ID": "MB-5261",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 116.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4660",
                    "Sample ID": "MB-4660",
                    "Nottingham prognostic index": 6.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4661",
                    "Sample ID": "MB-4661",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 234.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4663",
                    "Sample ID": "MB-4663",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.97,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 239.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4665",
                    "Sample ID": "MB-4665",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 260.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4666",
                    "Sample ID": "MB-4666",
                    "Nottingham prognostic index": 6.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4667",
                    "Sample ID": "MB-4667",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.58,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 295.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5272",
                    "Sample ID": "MB-5272",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.71,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 201.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4670",
                    "Sample ID": "MB-4670",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 67.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4671",
                    "Sample ID": "MB-4671",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4672",
                    "Sample ID": "MB-4672",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 220.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4673",
                    "Sample ID": "MB-4673",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 87,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4674",
                    "Sample ID": "MB-4674",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4675",
                    "Sample ID": "MB-4675",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 263.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4679",
                    "Sample ID": "MB-4679",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.11,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 292.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4681",
                    "Sample ID": "MB-4681",
                    "Nottingham prognostic index": 1.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 60.66,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 251.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 17,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5287",
                    "Sample ID": "MB-5287",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4685",
                    "Sample ID": "MB-4685",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4686",
                    "Sample ID": "MB-4686",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5290",
                    "Sample ID": "MB-5290",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4688",
                    "Sample ID": "MB-4688",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4691",
                    "Sample ID": "MB-4691",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 282.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5293",
                    "Sample ID": "MB-5293",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 208.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4694",
                    "Sample ID": "MB-4694",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 198.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5295",
                    "Sample ID": "MB-5295",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4696",
                    "Sample ID": "MB-4696",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 255.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4697",
                    "Sample ID": "MB-4697",
                    "Nottingham prognostic index": 1.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 79.01,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 118,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "NC",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4698",
                    "Sample ID": "MB-4698",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.18,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 170.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4701",
                    "Sample ID": "MB-4701",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 127.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5301",
                    "Sample ID": "MB-5301",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.46,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 241.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4704",
                    "Sample ID": "MB-4704",
                    "Nottingham prognostic index": 4.098,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 49,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5305",
                    "Sample ID": "MB-5305",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4706",
                    "Sample ID": "MB-4706",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4707",
                    "Sample ID": "MB-4707",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 221.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4708",
                    "Sample ID": "MB-4708",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.03,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 227.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5311",
                    "Sample ID": "MB-5311",
                    "Nottingham prognostic index": 3.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5312",
                    "Sample ID": "MB-5312",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5313",
                    "Sample ID": "MB-5313",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 79.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 46.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5315",
                    "Sample ID": "MB-5315",
                    "Nottingham prognostic index": 6.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 80,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5317",
                    "Sample ID": "MB-5317",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.7,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 53.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5318",
                    "Sample ID": "MB-5318",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5322",
                    "Sample ID": "MB-5322",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5323",
                    "Sample ID": "MB-5323",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 31.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 226.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5324",
                    "Sample ID": "MB-5324",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 190.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5325",
                    "Sample ID": "MB-5325",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.04,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 204.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 80,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5326",
                    "Sample ID": "MB-5326",
                    "Nottingham prognostic index": 2.096,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 79.26,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 96.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 48,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5327",
                    "Sample ID": "MB-5327",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 163.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5328",
                    "Sample ID": "MB-5328",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5329",
                    "Sample ID": "MB-5329",
                    "Nottingham prognostic index": 6.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.64,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 45.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 65,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5330",
                    "Sample ID": "MB-5330",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5331",
                    "Sample ID": "MB-5331",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5332",
                    "Sample ID": "MB-5332",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5334",
                    "Sample ID": "MB-5334",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5335",
                    "Sample ID": "MB-5335",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 25.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5338",
                    "Sample ID": "MB-5338",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4735",
                    "Sample ID": "MB-4735",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 297.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5341",
                    "Sample ID": "MB-5341",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 250.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5345",
                    "Sample ID": "MB-5345",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 216.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5346",
                    "Sample ID": "MB-5346",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 80,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5347",
                    "Sample ID": "MB-5347",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4742",
                    "Sample ID": "MB-4742",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 76.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 83.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5349",
                    "Sample ID": "MB-5349",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.88,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 191,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5350",
                    "Sample ID": "MB-5350",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 53.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5351",
                    "Sample ID": "MB-5351",
                    "Nottingham prognostic index": 4.004,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 202.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 2,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5358",
                    "Sample ID": "MB-5358",
                    "Nottingham prognostic index": 4.114,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.88,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 28.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 57,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5360",
                    "Sample ID": "MB-5360",
                    "Nottingham prognostic index": 3.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 161.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 70,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5361",
                    "Sample ID": "MB-5361",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5364",
                    "Sample ID": "MB-5364",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5365",
                    "Sample ID": "MB-5365",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5366",
                    "Sample ID": "MB-5366",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 243.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5368",
                    "Sample ID": "MB-5368",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 100.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5369",
                    "Sample ID": "MB-5369",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5370",
                    "Sample ID": "MB-5370",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.55,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 119.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5373",
                    "Sample ID": "MB-5373",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 2.533333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5377",
                    "Sample ID": "MB-5377",
                    "Nottingham prognostic index": 6.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5378",
                    "Sample ID": "MB-5378",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 12.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5381",
                    "Sample ID": "MB-5381",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 201.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5382",
                    "Sample ID": "MB-5382",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 116.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5383",
                    "Sample ID": "MB-5383",
                    "Nottingham prognostic index": 4.15,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 83.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 113.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 75,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5384",
                    "Sample ID": "MB-5384",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5385",
                    "Sample ID": "MB-5385",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 83.32,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 148.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5386",
                    "Sample ID": "MB-5386",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 192.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5387",
                    "Sample ID": "MB-5387",
                    "Nottingham prognostic index": 5.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.33,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 45.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 13,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5388",
                    "Sample ID": "MB-5388",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5389",
                    "Sample ID": "MB-5389",
                    "Nottingham prognostic index": 3.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5390",
                    "Sample ID": "MB-5390",
                    "Nottingham prognostic index": 6.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5392",
                    "Sample ID": "MB-5392",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 237.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5393",
                    "Sample ID": "MB-5393",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 154,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5394",
                    "Sample ID": "MB-5394",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.18,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 193.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5395",
                    "Sample ID": "MB-5395",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 165.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5396",
                    "Sample ID": "MB-5396",
                    "Nottingham prognostic index": 4.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 165.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5397",
                    "Sample ID": "MB-5397",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 172.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5398",
                    "Sample ID": "MB-5398",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 213,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5399",
                    "Sample ID": "MB-5399",
                    "Nottingham prognostic index": 2.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 73.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 106.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5401",
                    "Sample ID": "MB-5401",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.16666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5402",
                    "Sample ID": "MB-5402",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 107.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5403",
                    "Sample ID": "MB-5403",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 85.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 95.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5404",
                    "Sample ID": "MB-5404",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 74.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5405",
                    "Sample ID": "MB-5405",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5406",
                    "Sample ID": "MB-5406",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 80.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 97.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5407",
                    "Sample ID": "MB-5407",
                    "Nottingham prognostic index": 4.002,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 205.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 1,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5408",
                    "Sample ID": "MB-5408",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5409",
                    "Sample ID": "MB-5409",
                    "Nottingham prognostic index": 6.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 198.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4825",
                    "Sample ID": "MB-4825",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 214.4333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5411",
                    "Sample ID": "MB-5411",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 26,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4828",
                    "Sample ID": "MB-4828",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.87,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 42.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 80,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5413",
                    "Sample ID": "MB-5413",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.38,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 157.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5414",
                    "Sample ID": "MB-5414",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5417",
                    "Sample ID": "MB-5417",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 107.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5418",
                    "Sample ID": "MB-5418",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 207.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5420",
                    "Sample ID": "MB-5420",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5421",
                    "Sample ID": "MB-5421",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5422",
                    "Sample ID": "MB-5422",
                    "Nottingham prognostic index": 2.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 47.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 46.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5424",
                    "Sample ID": "MB-5424",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 83.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5425",
                    "Sample ID": "MB-5425",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5426",
                    "Sample ID": "MB-5426",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5427",
                    "Sample ID": "MB-5427",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 83.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 155.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5428",
                    "Sample ID": "MB-5428",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5429",
                    "Sample ID": "MB-5429",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 86.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5431",
                    "Sample ID": "MB-5431",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5432",
                    "Sample ID": "MB-5432",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5433",
                    "Sample ID": "MB-5433",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 176.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5434",
                    "Sample ID": "MB-5434",
                    "Nottingham prognostic index": 5.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5435",
                    "Sample ID": "MB-5435",
                    "Nottingham prognostic index": 1.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 77.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5440",
                    "Sample ID": "MB-5440",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.05,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 196.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5441",
                    "Sample ID": "MB-5441",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 90.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 9.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5442",
                    "Sample ID": "MB-5442",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 205.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5444",
                    "Sample ID": "MB-5444",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 49.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 240.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5446",
                    "Sample ID": "MB-5446",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 162.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5447",
                    "Sample ID": "MB-5447",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 148.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5450",
                    "Sample ID": "MB-5450",
                    "Nottingham prognostic index": 4.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 190.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5451",
                    "Sample ID": "MB-5451",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 189.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5452",
                    "Sample ID": "MB-5452",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5453",
                    "Sample ID": "MB-5453",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5454",
                    "Sample ID": "MB-5454",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5455",
                    "Sample ID": "MB-5455",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 61.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4882",
                    "Sample ID": "MB-4882",
                    "Nottingham prognostic index": 2.014,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 266.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 7,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5458",
                    "Sample ID": "MB-5458",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 183.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5459",
                    "Sample ID": "MB-5459",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5460",
                    "Sample ID": "MB-5460",
                    "Nottingham prognostic index": 4.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.59,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 218.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 5,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5463",
                    "Sample ID": "MB-5463",
                    "Nottingham prognostic index": 3.096,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 71.91,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 58.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 48,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5464",
                    "Sample ID": "MB-5464",
                    "Nottingham prognostic index": 2.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 65.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 116.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5465",
                    "Sample ID": "MB-5465",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 18.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5467",
                    "Sample ID": "MB-5467",
                    "Nottingham prognostic index": 4.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.01,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 186.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5468",
                    "Sample ID": "MB-5468",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.1,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 99.36666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5470",
                    "Sample ID": "MB-5470",
                    "Nottingham prognostic index": 2,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 48.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5471",
                    "Sample ID": "MB-5471",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5472",
                    "Sample ID": "MB-5472",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5473",
                    "Sample ID": "MB-5473",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5474",
                    "Sample ID": "MB-5474",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 226.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7084",
                    "Sample ID": "MB-7084",
                    "Nottingham prognostic index": 4.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 116.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7085",
                    "Sample ID": "MB-7085",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.5,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 110.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7086",
                    "Sample ID": "MB-7086",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5481",
                    "Sample ID": "MB-5481",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "UNDEF",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 46.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7088",
                    "Sample ID": "MB-7088",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7089",
                    "Sample ID": "MB-7089",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7090",
                    "Sample ID": "MB-7090",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 109.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5485",
                    "Sample ID": "MB-5485",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7092",
                    "Sample ID": "MB-7092",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 55.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7093",
                    "Sample ID": "MB-7093",
                    "Nottingham prognostic index": 3.0338,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16.9,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7094",
                    "Sample ID": "MB-7094",
                    "Nottingham prognostic index": 4.0488,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 113.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24.4,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5491",
                    "Sample ID": "MB-5491",
                    "Nottingham prognostic index": 4.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 65,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7096",
                    "Sample ID": "MB-7096",
                    "Nottingham prognostic index": 4.025,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7097",
                    "Sample ID": "MB-7097",
                    "Nottingham prognostic index": 2.0806,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 60.09,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 65.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 40.3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7099",
                    "Sample ID": "MB-7099",
                    "Nottingham prognostic index": 4.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.31,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 163.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 38,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7100",
                    "Sample ID": "MB-7100",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 156.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7101",
                    "Sample ID": "MB-7101",
                    "Nottingham prognostic index": 3.031,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 124.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7102",
                    "Sample ID": "MB-7102",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 73.16,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 104.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7104",
                    "Sample ID": "MB-7104",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5505",
                    "Sample ID": "MB-5505",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5510",
                    "Sample ID": "MB-5510",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 103.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5511",
                    "Sample ID": "MB-5511",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 158.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4959",
                    "Sample ID": "MB-4959",
                    "Nottingham prognostic index": 2.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5514",
                    "Sample ID": "MB-5514",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5518",
                    "Sample ID": "MB-5518",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5519",
                    "Sample ID": "MB-5519",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 169.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5520",
                    "Sample ID": "MB-5520",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.49,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5521",
                    "Sample ID": "MB-5521",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.27,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 124.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 45,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7118",
                    "Sample ID": "MB-7118",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5526",
                    "Sample ID": "MB-5526",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.42,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 151.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5527",
                    "Sample ID": "MB-5527",
                    "Nottingham prognostic index": 5.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 180.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7122",
                    "Sample ID": "MB-7122",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 29.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7123",
                    "Sample ID": "MB-7123",
                    "Nottingham prognostic index": 2.072,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 56.97,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 137.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 36,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7124",
                    "Sample ID": "MB-7124",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 139.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7127",
                    "Sample ID": "MB-7127",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 52.43,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 135.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5533",
                    "Sample ID": "MB-5533",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 158.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7130",
                    "Sample ID": "MB-7130",
                    "Nottingham prognostic index": 5.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5535",
                    "Sample ID": "MB-5535",
                    "Nottingham prognostic index": 6.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 120.1333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-4987",
                    "Sample ID": "MB-4987",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.37,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 221.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7133",
                    "Sample ID": "MB-7133",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5543",
                    "Sample ID": "MB-5543",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5546",
                    "Sample ID": "MB-5546",
                    "Nottingham prognostic index": 3.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.96,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 233.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 5,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5547",
                    "Sample ID": "MB-5547",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-4996",
                    "Sample ID": "MB-4996",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 69.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 99.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5549",
                    "Sample ID": "MB-5549",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5550",
                    "Sample ID": "MB-5550",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 84.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 171.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5551",
                    "Sample ID": "MB-5551",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5552",
                    "Sample ID": "MB-5552",
                    "Nottingham prognostic index": 2.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 69.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5553",
                    "Sample ID": "MB-5553",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 154.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5011",
                    "Sample ID": "MB-5011",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5556",
                    "Sample ID": "MB-5556",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 225.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7149",
                    "Sample ID": "MB-7149",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7150",
                    "Sample ID": "MB-7150",
                    "Nottingham prognostic index": 4.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 37,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5017",
                    "Sample ID": "MB-5017",
                    "Nottingham prognostic index": 6.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5562",
                    "Sample ID": "MB-5562",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5563",
                    "Sample ID": "MB-5563",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.3,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 117.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5565",
                    "Sample ID": "MB-5565",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.27,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 194.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7155",
                    "Sample ID": "MB-7155",
                    "Nottingham prognostic index": 5.0344,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 149.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17.2,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7157",
                    "Sample ID": "MB-7157",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.86,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 219.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7158",
                    "Sample ID": "MB-7158",
                    "Nottingham prognostic index": 6.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.73,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 46.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7159",
                    "Sample ID": "MB-7159",
                    "Nottingham prognostic index": 4.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7160",
                    "Sample ID": "MB-7160",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 148.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7161",
                    "Sample ID": "MB-7161",
                    "Nottingham prognostic index": 5.092,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 121.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 46,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7162",
                    "Sample ID": "MB-7162",
                    "Nottingham prognostic index": 2.0276,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13.8,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7163",
                    "Sample ID": "MB-7163",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.81,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 52.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7164",
                    "Sample ID": "MB-7164",
                    "Nottingham prognostic index": 3.0314,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 49.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15.7,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7165",
                    "Sample ID": "MB-7165",
                    "Nottingham prognostic index": 5.364,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 28.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 147.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 182,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7167",
                    "Sample ID": "MB-7167",
                    "Nottingham prognostic index": 3.17,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.26,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 141.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 85,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7168",
                    "Sample ID": "MB-7168",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 150.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7170",
                    "Sample ID": "MB-7170",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 155.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7171",
                    "Sample ID": "MB-7171",
                    "Nottingham prognostic index": 5.062,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 160.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7172",
                    "Sample ID": "MB-7172",
                    "Nottingham prognostic index": 4.0366,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.7,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 149.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 18.3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7173",
                    "Sample ID": "MB-7173",
                    "Nottingham prognostic index": 3.0432,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.4,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 63.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 21.6,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7174",
                    "Sample ID": "MB-7174",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7176",
                    "Sample ID": "MB-7176",
                    "Nottingham prognostic index": 4.057,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7181",
                    "Sample ID": "MB-7181",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 157.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5596",
                    "Sample ID": "MB-5596",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.27,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 167.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7185",
                    "Sample ID": "MB-7185",
                    "Nottingham prognostic index": 5.0324,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16.2,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7186",
                    "Sample ID": "MB-7186",
                    "Nottingham prognostic index": 5.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 48.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 4.866666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 33,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7187",
                    "Sample ID": "MB-7187",
                    "Nottingham prognostic index": 3.0046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 2.3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7188",
                    "Sample ID": "MB-7188",
                    "Nottingham prognostic index": 1.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.45,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 188.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7189",
                    "Sample ID": "MB-7189",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 143.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7193",
                    "Sample ID": "MB-7193",
                    "Nottingham prognostic index": 4.0304,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 87.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15.2,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5605",
                    "Sample ID": "MB-5605",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 40.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7195",
                    "Sample ID": "MB-7195",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7196",
                    "Sample ID": "MB-7196",
                    "Nottingham prognostic index": 6.15,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 107.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 75,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7197",
                    "Sample ID": "MB-7197",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7198",
                    "Sample ID": "MB-7198",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7199",
                    "Sample ID": "MB-7199",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 76,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7200",
                    "Sample ID": "MB-7200",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 97.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7201",
                    "Sample ID": "MB-7201",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.07,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 163.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7205",
                    "Sample ID": "MB-7205",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 166.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7207",
                    "Sample ID": "MB-7207",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 43.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7208",
                    "Sample ID": "MB-7208",
                    "Nottingham prognostic index": 6.0622,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 31.1,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7212",
                    "Sample ID": "MB-7212",
                    "Nottingham prognostic index": 4.0286,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.26,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 52.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 14.3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5629",
                    "Sample ID": "MB-5629",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 103.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5632",
                    "Sample ID": "MB-5632",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 38.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7217",
                    "Sample ID": "MB-7217",
                    "Nottingham prognostic index": 1.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 62.61,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 90.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7218",
                    "Sample ID": "MB-7218",
                    "Nottingham prognostic index": 3.0252,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 57.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 165.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12.6,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5635",
                    "Sample ID": "MB-5635",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7220",
                    "Sample ID": "MB-7220",
                    "Nottingham prognostic index": 3.0502,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.97,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 183.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25.1,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7225",
                    "Sample ID": "MB-7225",
                    "Nottingham prognostic index": 5.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 55,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 38,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7226",
                    "Sample ID": "MB-7226",
                    "Nottingham prognostic index": 5.0352,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 53.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17.6,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7227",
                    "Sample ID": "MB-7227",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 63.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7228",
                    "Sample ID": "MB-7228",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 239.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7229",
                    "Sample ID": "MB-7229",
                    "Nottingham prognostic index": 5.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7230",
                    "Sample ID": "MB-7230",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7231",
                    "Sample ID": "MB-7231",
                    "Nottingham prognostic index": 1.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 68.41,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 199.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 38,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7232",
                    "Sample ID": "MB-7232",
                    "Nottingham prognostic index": 3.00424,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 177.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 2.12,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7233",
                    "Sample ID": "MB-7233",
                    "Nottingham prognostic index": 3.0426,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 222.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21.3,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7234",
                    "Sample ID": "MB-7234",
                    "Nottingham prognostic index": 4.016,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 222.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 8,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7235",
                    "Sample ID": "MB-7235",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7236",
                    "Sample ID": "MB-7236",
                    "Nottingham prognostic index": 5.04464,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 201.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22.32,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7237",
                    "Sample ID": "MB-7237",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "NC",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7238",
                    "Sample ID": "MB-7238",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7241",
                    "Sample ID": "MB-7241",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 171.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7243",
                    "Sample ID": "MB-7243",
                    "Nottingham prognostic index": 2.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 78.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 148.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7244",
                    "Sample ID": "MB-7244",
                    "Nottingham prognostic index": 3.024,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 54.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 184.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7249",
                    "Sample ID": "MB-7249",
                    "Nottingham prognostic index": 1.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 75.13,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 58.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7250",
                    "Sample ID": "MB-7250",
                    "Nottingham prognostic index": 4.0354,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 51,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17.7,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7251",
                    "Sample ID": "MB-7251",
                    "Nottingham prognostic index": 6.03094,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15.47,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7252",
                    "Sample ID": "MB-7252",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7253",
                    "Sample ID": "MB-7253",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.72,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 59.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7254",
                    "Sample ID": "MB-7254",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.46,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 192.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7256",
                    "Sample ID": "MB-7256",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7258",
                    "Sample ID": "MB-7258",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7260",
                    "Sample ID": "MB-7260",
                    "Nottingham prognostic index": 6.0483,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 31.16666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24.15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7262",
                    "Sample ID": "MB-7262",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 83.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7263",
                    "Sample ID": "MB-7263",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7264",
                    "Sample ID": "MB-7264",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7266",
                    "Sample ID": "MB-7266",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 68.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7267",
                    "Sample ID": "MB-7267",
                    "Nottingham prognostic index": 5.041,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 28.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 195.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7268",
                    "Sample ID": "MB-7268",
                    "Nottingham prognostic index": 5.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 34.64,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 227.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7269",
                    "Sample ID": "MB-7269",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6030",
                    "Sample ID": "MB-6030",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 66.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 145.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6036",
                    "Sample ID": "MB-6036",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.65,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 287.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6039",
                    "Sample ID": "MB-6039",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 73.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6042",
                    "Sample ID": "MB-6042",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 263.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7277",
                    "Sample ID": "MB-7277",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6047",
                    "Sample ID": "MB-6047",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7279",
                    "Sample ID": "MB-7279",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 86.14,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 21.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7280",
                    "Sample ID": "MB-7280",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 195.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6050",
                    "Sample ID": "MB-6050",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 192.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7283",
                    "Sample ID": "MB-7283",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.42,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 28.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7284",
                    "Sample ID": "MB-7284",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.23,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 203,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6053",
                    "Sample ID": "MB-6053",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 69.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 250.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6055",
                    "Sample ID": "MB-6055",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 33.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7287",
                    "Sample ID": "MB-7287",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 96.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6059",
                    "Sample ID": "MB-6059",
                    "Nottingham prognostic index": 4.096,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 278.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 48,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7289",
                    "Sample ID": "MB-7289",
                    "Nottingham prognostic index": 5.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.87,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 126.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 65,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7291",
                    "Sample ID": "MB-7291",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.87,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 6.833333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6063",
                    "Sample ID": "MB-6063",
                    "Nottingham prognostic index": 6.24,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 120,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7293",
                    "Sample ID": "MB-7293",
                    "Nottingham prognostic index": 5.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7294",
                    "Sample ID": "MB-7294",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 82.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7295",
                    "Sample ID": "MB-7295",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 196.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7296",
                    "Sample ID": "MB-7296",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 42.88,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6075",
                    "Sample ID": "MB-6075",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 84.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6077",
                    "Sample ID": "MB-6077",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.2666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "NC",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6079",
                    "Sample ID": "MB-6079",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 239.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6080",
                    "Sample ID": "MB-6080",
                    "Nottingham prognostic index": 6.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 54.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6082",
                    "Sample ID": "MB-6082",
                    "Nottingham prognostic index": 5.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 70,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6083",
                    "Sample ID": "MB-6083",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.03,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.0333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6085",
                    "Sample ID": "MB-6085",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5186",
                    "Sample ID": "MB-5186",
                    "Nottingham prognostic index": 1.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 42.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 203.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6097",
                    "Sample ID": "MB-6097",
                    "Nottingham prognostic index": 4.016,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 159.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 8,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6098",
                    "Sample ID": "MB-6098",
                    "Nottingham prognostic index": 5.16,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 28.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 10.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 80,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6100",
                    "Sample ID": "MB-6100",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 10.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5191",
                    "Sample ID": "MB-5191",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 142.1666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6103",
                    "Sample ID": "MB-6103",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.28,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 239.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6105",
                    "Sample ID": "MB-6105",
                    "Nottingham prognostic index": 2.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 78.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 192.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6107",
                    "Sample ID": "MB-6107",
                    "Nottingham prognostic index": 4,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.38,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 123.3333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6108",
                    "Sample ID": "MB-6108",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 38.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5199",
                    "Sample ID": "MB-5199",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 204.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6114",
                    "Sample ID": "MB-6114",
                    "Nottingham prognostic index": 5.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 66.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6116",
                    "Sample ID": "MB-6116",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 193.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5204",
                    "Sample ID": "MB-5204",
                    "Nottingham prognostic index": 2.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 76.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 191.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6122",
                    "Sample ID": "MB-6122",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 54.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 260.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6124",
                    "Sample ID": "MB-6124",
                    "Nottingham prognostic index": 6.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 115.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6125",
                    "Sample ID": "MB-6125",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 153.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6131",
                    "Sample ID": "MB-6131",
                    "Nottingham prognostic index": 3.122,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 257.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 61,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6133",
                    "Sample ID": "MB-6133",
                    "Nottingham prognostic index": 3.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.6,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 61.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 39,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6135",
                    "Sample ID": "MB-6135",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 78.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6138",
                    "Sample ID": "MB-6138",
                    "Nottingham prognostic index": 6.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.85,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 25.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 37,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5214",
                    "Sample ID": "MB-5214",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 107.3666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6143",
                    "Sample ID": "MB-6143",
                    "Nottingham prognostic index": 4.092,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.6,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 255.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 46,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6144",
                    "Sample ID": "MB-6144",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.55,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 254.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MED",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6145",
                    "Sample ID": "MB-6145",
                    "Nottingham prognostic index": 4.09,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.41,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 34.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 45,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5221",
                    "Sample ID": "MB-5221",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.53,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 131.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6147",
                    "Sample ID": "MB-6147",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.01,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 238.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6149",
                    "Sample ID": "MB-6149",
                    "Nottingham prognostic index": 2.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 70.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 74.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6150",
                    "Sample ID": "MB-6150",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 59.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 77.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5225",
                    "Sample ID": "MB-5225",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6154",
                    "Sample ID": "MB-6154",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 195.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6156",
                    "Sample ID": "MB-6156",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.5,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 58.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6157",
                    "Sample ID": "MB-6157",
                    "Nottingham prognostic index": 6.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 86.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 15.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6160",
                    "Sample ID": "MB-6160",
                    "Nottingham prognostic index": 4,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 46.23,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 247.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6163",
                    "Sample ID": "MB-6163",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6164",
                    "Sample ID": "MB-6164",
                    "Nottingham prognostic index": 5.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 205.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5232",
                    "Sample ID": "MB-5232",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 211.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6168",
                    "Sample ID": "MB-6168",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 225.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6169",
                    "Sample ID": "MB-6169",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.17,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6171",
                    "Sample ID": "MB-6171",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.91,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 220.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6178",
                    "Sample ID": "MB-6178",
                    "Nottingham prognostic index": 6.064,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 38.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 33.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5239",
                    "Sample ID": "MB-5239",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 192.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6181",
                    "Sample ID": "MB-6181",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 83.09,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 54.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6182",
                    "Sample ID": "MB-6182",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 208.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6183",
                    "Sample ID": "MB-6183",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5251",
                    "Sample ID": "MB-5251",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 76.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 112.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6185",
                    "Sample ID": "MB-6185",
                    "Nottingham prognostic index": 2.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 75.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 197.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5255",
                    "Sample ID": "MB-5255",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.7,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 53.56666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6188",
                    "Sample ID": "MB-6188",
                    "Nottingham prognostic index": 6.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 23.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6189",
                    "Sample ID": "MB-6189",
                    "Nottingham prognostic index": 3.084,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 240.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 42,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6190",
                    "Sample ID": "MB-6190",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5260",
                    "Sample ID": "MB-5260",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.23,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 202.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6194",
                    "Sample ID": "MB-6194",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.51,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 52.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5264",
                    "Sample ID": "MB-5264",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 46.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 199.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5266",
                    "Sample ID": "MB-5266",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 83.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5267",
                    "Sample ID": "MB-5267",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5268",
                    "Sample ID": "MB-5268",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 47.98,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 186.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5270",
                    "Sample ID": "MB-5270",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 187.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5271",
                    "Sample ID": "MB-5271",
                    "Nottingham prognostic index": 3.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 58.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 167.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6211",
                    "Sample ID": "MB-6211",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5273",
                    "Sample ID": "MB-5273",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 60.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5275",
                    "Sample ID": "MB-5275",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5277",
                    "Sample ID": "MB-5277",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 35.78,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 221.0666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5278",
                    "Sample ID": "MB-5278",
                    "Nottingham prognostic index": 1.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 47.92,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 99.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5279",
                    "Sample ID": "MB-5279",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.55,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 68.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5280",
                    "Sample ID": "MB-5280",
                    "Nottingham prognostic index": 4.004,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 77.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 2,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5281",
                    "Sample ID": "MB-5281",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 79.3,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5284",
                    "Sample ID": "MB-5284",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6226",
                    "Sample ID": "MB-6226",
                    "Nottingham prognostic index": 3.074,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.37,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 35.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 37,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5288",
                    "Sample ID": "MB-5288",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5289",
                    "Sample ID": "MB-5289",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.45,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 87,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6230",
                    "Sample ID": "MB-6230",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.95,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 74.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5291",
                    "Sample ID": "MB-5291",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 153.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5292",
                    "Sample ID": "MB-5292",
                    "Nottingham prognostic index": 3.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6233",
                    "Sample ID": "MB-6233",
                    "Nottingham prognostic index": 2.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 70.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 201.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5294",
                    "Sample ID": "MB-5294",
                    "Nottingham prognostic index": 6.198,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 31.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 195.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 99,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6237",
                    "Sample ID": "MB-6237",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 105.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5296",
                    "Sample ID": "MB-5296",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 13.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5298",
                    "Sample ID": "MB-5298",
                    "Nottingham prognostic index": 6.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 84.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5299",
                    "Sample ID": "MB-5299",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5300",
                    "Sample ID": "MB-5300",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 55.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 190.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6246",
                    "Sample ID": "MB-6246",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 52.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5302",
                    "Sample ID": "MB-5302",
                    "Nottingham prognostic index": 2.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 52.81,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 191.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 60,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6251",
                    "Sample ID": "MB-6251",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 14.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5306",
                    "Sample ID": "MB-5306",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 159.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5308",
                    "Sample ID": "MB-5308",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 104.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5310",
                    "Sample ID": "MB-5310",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 153.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6257",
                    "Sample ID": "MB-6257",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6263",
                    "Sample ID": "MB-6263",
                    "Nottingham prognostic index": 5.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 75.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6271",
                    "Sample ID": "MB-6271",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.4,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 157.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6272",
                    "Sample ID": "MB-6272",
                    "Nottingham prognostic index": 5,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 22.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6273",
                    "Sample ID": "MB-6273",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 189.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6280",
                    "Sample ID": "MB-6280",
                    "Nottingham prognostic index": 5.088,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 53.68,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 44,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6281",
                    "Sample ID": "MB-6281",
                    "Nottingham prognostic index": 5.01,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.1,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 3.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6283",
                    "Sample ID": "MB-6283",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.07,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 92.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6284",
                    "Sample ID": "MB-6284",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6286",
                    "Sample ID": "MB-6286",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 85.17,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 49.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6287",
                    "Sample ID": "MB-6287",
                    "Nottingham prognostic index": 5.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6288",
                    "Sample ID": "MB-6288",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 100.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6297",
                    "Sample ID": "MB-6297",
                    "Nottingham prognostic index": 3.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 170.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6300",
                    "Sample ID": "MB-6300",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.92,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 63.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6302",
                    "Sample ID": "MB-6302",
                    "Nottingham prognostic index": 6.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 125.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6305",
                    "Sample ID": "MB-6305",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6306",
                    "Sample ID": "MB-6306",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 78.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6308",
                    "Sample ID": "MB-6308",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 151.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6312",
                    "Sample ID": "MB-6312",
                    "Nottingham prognostic index": 4.078,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 85.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 162.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 39,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6314",
                    "Sample ID": "MB-6314",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 134.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5339",
                    "Sample ID": "MB-5339",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.78,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 195.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "NC",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6318",
                    "Sample ID": "MB-6318",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 81.37,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 109.2333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6319",
                    "Sample ID": "MB-6319",
                    "Nottingham prognostic index": 5.124,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.9,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 154.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 62,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6322",
                    "Sample ID": "MB-6322",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6327",
                    "Sample ID": "MB-6327",
                    "Nottingham prognostic index": 4.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 76.56,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 18.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 60,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5348",
                    "Sample ID": "MB-5348",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 169.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6329",
                    "Sample ID": "MB-6329",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6330",
                    "Sample ID": "MB-6330",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 36.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6334",
                    "Sample ID": "MB-6334",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6336",
                    "Sample ID": "MB-6336",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.22,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 17.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6337",
                    "Sample ID": "MB-6337",
                    "Nottingham prognostic index": 6.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.8666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6344",
                    "Sample ID": "MB-6344",
                    "Nottingham prognostic index": 3.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 152.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6346",
                    "Sample ID": "MB-6346",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 281.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6358",
                    "Sample ID": "MB-6358",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 57.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6359",
                    "Sample ID": "MB-6359",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 73.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6363",
                    "Sample ID": "MB-6363",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 16.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7000",
                    "Sample ID": "MB-7000",
                    "Nottingham prognostic index": 4.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.28,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 97.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 11,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7001",
                    "Sample ID": "MB-7001",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.71,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 102.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7002",
                    "Sample ID": "MB-7002",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 57.93333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7003",
                    "Sample ID": "MB-7003",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7004",
                    "Sample ID": "MB-7004",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.2,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.46666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7005",
                    "Sample ID": "MB-7005",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 70.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 45.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7006",
                    "Sample ID": "MB-7006",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 58.8,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 109.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7007",
                    "Sample ID": "MB-7007",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 58.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7008",
                    "Sample ID": "MB-7008",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 50.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7009",
                    "Sample ID": "MB-7009",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.28,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 54.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7010",
                    "Sample ID": "MB-7010",
                    "Nottingham prognostic index": 2.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 70.25,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 74.03333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7011",
                    "Sample ID": "MB-7011",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7012",
                    "Sample ID": "MB-7012",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 19.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7013",
                    "Sample ID": "MB-7013",
                    "Nottingham prognostic index": 2.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 30.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 46.43333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7014",
                    "Sample ID": "MB-7014",
                    "Nottingham prognostic index": 5.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 68.7,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7015",
                    "Sample ID": "MB-7015",
                    "Nottingham prognostic index": 4.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 63.79,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 78.16666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7017",
                    "Sample ID": "MB-7017",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.63,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 135.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7018",
                    "Sample ID": "MB-7018",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7019",
                    "Sample ID": "MB-7019",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7020",
                    "Sample ID": "MB-7020",
                    "Nottingham prognostic index": 5.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7022",
                    "Sample ID": "MB-7022",
                    "Nottingham prognostic index": 3.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7023",
                    "Sample ID": "MB-7023",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.66,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7024",
                    "Sample ID": "MB-7024",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.92,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 70.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7025",
                    "Sample ID": "MB-7025",
                    "Nottingham prognostic index": 4.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 80.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7026",
                    "Sample ID": "MB-7026",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 35.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7027",
                    "Sample ID": "MB-7027",
                    "Nottingham prognostic index": 6.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.96666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7028",
                    "Sample ID": "MB-7028",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 65.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7029",
                    "Sample ID": "MB-7029",
                    "Nottingham prognostic index": 2.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 43.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 76.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7030",
                    "Sample ID": "MB-7030",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.21,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 31.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7031",
                    "Sample ID": "MB-7031",
                    "Nottingham prognostic index": 5.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.58,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.36666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7032",
                    "Sample ID": "MB-7032",
                    "Nottingham prognostic index": 2.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 79.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.46666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7034",
                    "Sample ID": "MB-7034",
                    "Nottingham prognostic index": 3.086,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.73,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 75.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 43,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5410",
                    "Sample ID": "MB-5410",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 202.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7036",
                    "Sample ID": "MB-7036",
                    "Nottingham prognostic index": 5.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 120.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5412",
                    "Sample ID": "MB-5412",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 51.87,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 220.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 14,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7038",
                    "Sample ID": "MB-7038",
                    "Nottingham prognostic index": 5.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 81.03333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7039",
                    "Sample ID": "MB-7039",
                    "Nottingham prognostic index": 4.124,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.19,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 49.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 62,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7040",
                    "Sample ID": "MB-7040",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 81.32,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 71.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7041",
                    "Sample ID": "MB-7041",
                    "Nottingham prognostic index": 1.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 79.48,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 101.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7042",
                    "Sample ID": "MB-7042",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.72,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7043",
                    "Sample ID": "MB-7043",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 72.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.53333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7044",
                    "Sample ID": "MB-7044",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.83333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7045",
                    "Sample ID": "MB-7045",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.39,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 94.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7046",
                    "Sample ID": "MB-7046",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 76.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 146.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7048",
                    "Sample ID": "MB-7048",
                    "Nottingham prognostic index": 3.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 36.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.46666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7049",
                    "Sample ID": "MB-7049",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 48.75,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.0333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7050",
                    "Sample ID": "MB-7050",
                    "Nottingham prognostic index": 4.045,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 65.13333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7051",
                    "Sample ID": "MB-7051",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.44,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7052",
                    "Sample ID": "MB-7052",
                    "Nottingham prognostic index": 4.0358,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 106.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17.9,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7053",
                    "Sample ID": "MB-7053",
                    "Nottingham prognostic index": 4.029,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 122.1333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7054",
                    "Sample ID": "MB-7054",
                    "Nottingham prognostic index": 5.0256,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 73.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12.8,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7055",
                    "Sample ID": "MB-7055",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 9.133333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7056",
                    "Sample ID": "MB-7056",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.82,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7057",
                    "Sample ID": "MB-7057",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 72.81,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 43.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7058",
                    "Sample ID": "MB-7058",
                    "Nottingham prognostic index": 3.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 45.81,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 122.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7059",
                    "Sample ID": "MB-7059",
                    "Nottingham prognostic index": 6.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 119.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7060",
                    "Sample ID": "MB-7060",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 69.25,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 112.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7061",
                    "Sample ID": "MB-7061",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 96.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7062",
                    "Sample ID": "MB-7062",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 63.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 95.86666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7063",
                    "Sample ID": "MB-7063",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.77,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7065",
                    "Sample ID": "MB-7065",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 45.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 107.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7066",
                    "Sample ID": "MB-7066",
                    "Nottingham prognostic index": 5.037,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 64.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7067",
                    "Sample ID": "MB-7067",
                    "Nottingham prognostic index": 3.031,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 105,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7068",
                    "Sample ID": "MB-7068",
                    "Nottingham prognostic index": 4.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.95,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.46666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7069",
                    "Sample ID": "MB-7069",
                    "Nottingham prognostic index": 4.043,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.6,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5457",
                    "Sample ID": "MB-5457",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 164.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7071",
                    "Sample ID": "MB-7071",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 27.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7072",
                    "Sample ID": "MB-7072",
                    "Nottingham prognostic index": 5.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.24,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 52.33333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 65,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7073",
                    "Sample ID": "MB-7073",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.69,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 137.9333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7074",
                    "Sample ID": "MB-7074",
                    "Nottingham prognostic index": 2.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 51.36,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7075",
                    "Sample ID": "MB-7075",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 64.4,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 111.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7076",
                    "Sample ID": "MB-7076",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 142.6666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7077",
                    "Sample ID": "MB-7077",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 37.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 101.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7078",
                    "Sample ID": "MB-7078",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 74.8,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 4.166666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7079",
                    "Sample ID": "MB-7079",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 70.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.06666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7080",
                    "Sample ID": "MB-7080",
                    "Nottingham prognostic index": 2.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 64.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 91.23333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7081",
                    "Sample ID": "MB-7081",
                    "Nottingham prognostic index": 4.056,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 69.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 28,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7082",
                    "Sample ID": "MB-7082",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 57.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 98.26666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7083",
                    "Sample ID": "MB-7083",
                    "Nottingham prognostic index": 3.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 50.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 105.4666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6245",
                    "Sample ID": "MB-6245",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.01,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 177.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7137",
                    "Sample ID": "MB-7137",
                    "Nottingham prognostic index": 2.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": null,
                    "Age at Diagnosis": 64.24,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 179.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6248",
                    "Sample ID": "MB-6248",
                    "Nottingham prognostic index": 5.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 182.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7087",
                    "Sample ID": "MB-7087",
                    "Nottingham prognostic index": 5.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.61,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 5.066666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6253",
                    "Sample ID": "MB-6253",
                    "Nottingham prognostic index": 2.022,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 62.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 194.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 11,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6254",
                    "Sample ID": "MB-6254",
                    "Nottingham prognostic index": 3.142,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.69,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 60.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 71,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6256",
                    "Sample ID": "MB-6256",
                    "Nottingham prognostic index": 2.028,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 67.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 127.8333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 14,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7091",
                    "Sample ID": "MB-7091",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 55.71,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7145",
                    "Sample ID": "MB-7145",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 44.42,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 138.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5554",
                    "Sample ID": "MB-5554",
                    "Nottingham prognostic index": 2.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 57.75,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 229.8333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7148",
                    "Sample ID": "MB-7148",
                    "Nottingham prognostic index": 6.26,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.97,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 19,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 130,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7095",
                    "Sample ID": "MB-7095",
                    "Nottingham prognostic index": 2.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 74.64,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 115.6333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6192",
                    "Sample ID": "MB-6192",
                    "Nottingham prognostic index": 4.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.45,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7270",
                    "Sample ID": "MB-7270",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 50.84,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 175.1666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7273",
                    "Sample ID": "MB-7273",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 47.47,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 208.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7275",
                    "Sample ID": "MB-7275",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 30.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 44.4,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7276",
                    "Sample ID": "MB-7276",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 61.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6204",
                    "Sample ID": "MB-6204",
                    "Nottingham prognostic index": 4.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 56.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7278",
                    "Sample ID": "MB-7278",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 67.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 241.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7106",
                    "Sample ID": "MB-7106",
                    "Nottingham prognostic index": 4.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 80.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7107",
                    "Sample ID": "MB-7107",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.85,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 56.93333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7109",
                    "Sample ID": "MB-7109",
                    "Nottingham prognostic index": 6.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 67.27,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 117.5333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5513",
                    "Sample ID": "MB-5513",
                    "Nottingham prognostic index": 5.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 86.55,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 36.63333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7112",
                    "Sample ID": "MB-7112",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 40.74,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 64.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7113",
                    "Sample ID": "MB-7113",
                    "Nottingham prognostic index": 2.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 66.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 136.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7114",
                    "Sample ID": "MB-7114",
                    "Nottingham prognostic index": 4.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 55.57,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123.2666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7115",
                    "Sample ID": "MB-7115",
                    "Nottingham prognostic index": 4.14,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 80.56,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 141.7333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 70,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7116",
                    "Sample ID": "MB-7116",
                    "Nottingham prognostic index": 4.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 77.17,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 33.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 40,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6225",
                    "Sample ID": "MB-6225",
                    "Nottingham prognostic index": 3.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 68.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 117.8666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7119",
                    "Sample ID": "MB-7119",
                    "Nottingham prognostic index": 5.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 54.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 128.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7121",
                    "Sample ID": "MB-7121",
                    "Nottingham prognostic index": 6.076,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 88.83333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 38,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6229",
                    "Sample ID": "MB-6229",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 75.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 0.1,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6328",
                    "Sample ID": "MB-6328",
                    "Nottingham prognostic index": 2.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 75.89,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 126.6666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6231",
                    "Sample ID": "MB-6231",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 72.56666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6232",
                    "Sample ID": "MB-6232",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 85,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7128",
                    "Sample ID": "MB-7128",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 71.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 60.26666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7298",
                    "Sample ID": "MB-7298",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 86.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7131",
                    "Sample ID": "MB-7131",
                    "Nottingham prognostic index": 5.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 134.7333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5540",
                    "Sample ID": "MB-5540",
                    "Nottingham prognostic index": 6.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 48.43333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7132",
                    "Sample ID": "MB-7132",
                    "Nottingham prognostic index": 3.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 131.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7135",
                    "Sample ID": "MB-7135",
                    "Nottingham prognostic index": 6.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 56.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 26.73333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7152",
                    "Sample ID": "MB-7152",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 195.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7138",
                    "Sample ID": "MB-7138",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.16,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 123,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-5548",
                    "Sample ID": "MB-5548",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 25.33333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7141",
                    "Sample ID": "MB-7141",
                    "Nottingham prognostic index": 3.0236,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 78.16,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 138.5666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 11.8,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7142",
                    "Sample ID": "MB-7142",
                    "Nottingham prognostic index": 3.026,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 13,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7143",
                    "Sample ID": "MB-7143",
                    "Nottingham prognostic index": 4.068,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.38,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 186.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 34,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7144",
                    "Sample ID": "MB-7144",
                    "Nottingham prognostic index": 4.045,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.34,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 102.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6187",
                    "Sample ID": "MB-6187",
                    "Nottingham prognostic index": 4.158,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 70.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 37.76666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 79,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6141",
                    "Sample ID": "MB-6141",
                    "Nottingham prognostic index": 6,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 79.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 78.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6214",
                    "Sample ID": "MB-6214",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.43,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 174.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6113",
                    "Sample ID": "MB-6113",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 39.41,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 124.5666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6218",
                    "Sample ID": "MB-6218",
                    "Nottingham prognostic index": 4.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 49.67,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 147.7666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-5560",
                    "Sample ID": "MB-5560",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 3,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 44.05,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 186.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6224",
                    "Sample ID": "MB-6224",
                    "Nottingham prognostic index": 6.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.94,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 35.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 10,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7153",
                    "Sample ID": "MB-7153",
                    "Nottingham prognostic index": 3.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 74.11,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 142.8,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7154",
                    "Sample ID": "MB-7154",
                    "Nottingham prognostic index": 4.0652,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 77.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 32.6,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6201",
                    "Sample ID": "MB-6201",
                    "Nottingham prognostic index": 3.02,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.2,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 222.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 10,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6207",
                    "Sample ID": "MB-6207",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 118.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7219",
                    "Sample ID": "MB-7219",
                    "Nottingham prognostic index": 3.025,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 60.07,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 165.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 12.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6208",
                    "Sample ID": "MB-6208",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 56.93,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 221.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6212",
                    "Sample ID": "MB-6212",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 61.81,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 224.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7035",
                    "Sample ID": "MB-7035",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 45.3,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 32.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7182",
                    "Sample ID": "MB-7182",
                    "Nottingham prognostic index": 4.054,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.26,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 27,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6217",
                    "Sample ID": "MB-6217",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 47.51,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 211.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6238",
                    "Sample ID": "MB-6238",
                    "Nottingham prognostic index": 3.058,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 84.87,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 172.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 29,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6146",
                    "Sample ID": "MB-6146",
                    "Nottingham prognostic index": 5.012,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.04,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 89.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 6,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6242",
                    "Sample ID": "MB-6242",
                    "Nottingham prognostic index": 6.11,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 41.29,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 165.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 55,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7288",
                    "Sample ID": "MB-7288",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 55.7,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 27.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7070",
                    "Sample ID": "MB-7070",
                    "Nottingham prognostic index": 5.004,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 68.76,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.0666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 2,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6152",
                    "Sample ID": "MB-6152",
                    "Nottingham prognostic index": 3.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.62,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 228.9,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7292",
                    "Sample ID": "MB-7292",
                    "Nottingham prognostic index": 4.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 78.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7140",
                    "Sample ID": "MB-7140",
                    "Nottingham prognostic index": 6.12,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.27,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 90.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 60,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6184",
                    "Sample ID": "MB-6184",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 35.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 185.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6101",
                    "Sample ID": "MB-6101",
                    "Nottingham prognostic index": 3.07,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 82.51,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 77.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "INVASIVE TUMOUR",
                    "Tumor Size": 35,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6239",
                    "Sample ID": "MB-6239",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 52.84,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.3333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6213",
                    "Sample ID": "MB-6213",
                    "Nottingham prognostic index": 3.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "7",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.75,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 203.5333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6167",
                    "Sample ID": "MB-6167",
                    "Nottingham prognostic index": 5.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 75.02,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 122.8,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7147",
                    "Sample ID": "MB-7147",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.98,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 168.6,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7194",
                    "Sample ID": "MB-7194",
                    "Nottingham prognostic index": 3.043,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 63.71,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 46.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 21.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6223",
                    "Sample ID": "MB-6223",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 58.83,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 221.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6195",
                    "Sample ID": "MB-6195",
                    "Nottingham prognostic index": 3.046,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.01,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 202.2333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 23,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6179",
                    "Sample ID": "MB-6179",
                    "Nottingham prognostic index": 2.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 59.08,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 58.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 33,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7111",
                    "Sample ID": "MB-7111",
                    "Nottingham prognostic index": 6.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 52.12,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.16666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 50,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6228",
                    "Sample ID": "MB-6228",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 37.33,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 200.1,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7151",
                    "Sample ID": "MB-7151",
                    "Nottingham prognostic index": 4.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.06,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 144.4333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Basal",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6234",
                    "Sample ID": "MB-6234",
                    "Nottingham prognostic index": 3,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 66.35,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 213.3666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": null,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7215",
                    "Sample ID": "MB-7215",
                    "Nottingham prognostic index": 4.031,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 60.15,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 208.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 15.5,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7285",
                    "Sample ID": "MB-7285",
                    "Nottingham prognostic index": 4.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "6",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 53.14,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 109,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "OTHER INVASIVE",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7037",
                    "Sample ID": "MB-7037",
                    "Nottingham prognostic index": 2.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 1,
                    "Age at Diagnosis": 68.74,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 86.4,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-TUB",
                    "Tumor Size": 15,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-7286",
                    "Sample ID": "MB-7286",
                    "Nottingham prognostic index": 5.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.48,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 158.6333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7281",
                    "Sample ID": "MB-7281",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 4,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.22,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 49.53333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7216",
                    "Sample ID": "MB-7216",
                    "Nottingham prognostic index": 3.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 79.23,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 207.4666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC-MUC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-6092",
                    "Sample ID": "MB-6092",
                    "Nottingham prognostic index": 3.042,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 80.59,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 2.3,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 21,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6200",
                    "Sample ID": "MB-6200",
                    "Nottingham prognostic index": 5.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 65.52,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 30.06666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7297",
                    "Sample ID": "MB-7297",
                    "Nottingham prognostic index": 6.05,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 62.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 175.9666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 25,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-7299",
                    "Sample ID": "MB-7299",
                    "Nottingham prognostic index": 5.04,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 4,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "10",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.02,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 201.9,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 20,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6118",
                    "Sample ID": "MB-6118",
                    "Nottingham prognostic index": 3.03,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 41.11,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 264.6,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 15,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-6317",
                    "Sample ID": "MB-6317",
                    "Nottingham prognostic index": 5.106,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 5,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "2",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 86.9,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 29.23333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Other Causes",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 53,
                    "Tumor Stage": null,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0000",
                    "Sample ID": "MB-0000",
                    "Nottingham prognostic index": 6.044,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 75.65,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 140.5,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 22,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0008",
                    "Sample ID": "MB-0008",
                    "Nottingham prognostic index": 6.08,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 76.97,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 41.36666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 40,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0064",
                    "Sample ID": "MB-0064",
                    "Nottingham prognostic index": 3.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "3",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 69.13,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 108.9333333,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0108",
                    "Sample ID": "MB-0108",
                    "Nottingham prognostic index": 4.036,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 43.15,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 42.7,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 18,
                    "Tumor Stage": 1,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0113",
                    "Sample ID": "MB-0113",
                    "Nottingham prognostic index": 5.034,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 36.96,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 43.16666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 17,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0124",
                    "Sample ID": "MB-0124",
                    "Nottingham prognostic index": 4.1,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Mixed Ductal and Lobular Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 43.46,
                    "Oncotree Code": "MDLC",
                    "Overall Survival (Months)": 118.2,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumA",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC+ILC",
                    "Tumor Size": 50,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0157",
                    "Sample ID": "MB-0157",
                    "Nottingham prognostic index": 4.06,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 71.5,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 114.7666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 30,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0174",
                    "Sample ID": "MB-0174",
                    "Nottingham prognostic index": 4.048,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "low",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER-",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 59.18,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 78.76666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER-/HER2-",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 24,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0268",
                    "Sample ID": "MB-0268",
                    "Nottingham prognostic index": 4.038,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "9",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 66.54,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 28.5,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 19,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": ""
                }, {
                    "Patient ID": "MB-0283",
                    "Sample ID": "MB-0283",
                    "Nottingham prognostic index": 6.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Invasive Breast Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "1",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 60.3,
                    "Oncotree Code": "BRCA",
                    "Overall Survival (Months)": 22.03333333,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- High Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 33,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0291",
                    "Sample ID": "MB-0291",
                    "Nottingham prognostic index": 5.052,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 51.19,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 39.2,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "NO",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 26,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0444",
                    "Sample ID": "MB-0444",
                    "Nottingham prognostic index": 5.066,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "NO",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "NEUT",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "8",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 49.87,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 55.46666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "+",
                    "Pam50 + Claudin-low subtype": "LumB",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 33,
                    "Tumor Stage": 4,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0482",
                    "Sample ID": "MB-0482",
                    "Nottingham prognostic index": 5.032,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "pre",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 39.53,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 24.86666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Normal",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 16,
                    "Tumor Stage": 2,
                    "Type of Breast Surgery": "BREAST CONSERVING"
                }, {
                    "Patient ID": "MB-0519",
                    "Sample ID": "MB-0519",
                    "Nottingham prognostic index": 6.13,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Ductal Carcinoma",
                    "Cellularity": "moderate",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "+",
                    "ER status measured by IHC": "pos",
                    "HER2 Status": "-",
                    "HER2 status measured by SNP6": "LOSS",
                    "Hormone Therapy": "YES",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "4ER+",
                    "Neoplasm Histologic Grade": 3,
                    "Age at Diagnosis": 61.99,
                    "Oncotree Code": "IDC",
                    "Overall Survival (Months)": 110.9666667,
                    "Overall Survival Status": "LIVING",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "claudin-low",
                    "3-Gene classifier subtype": "ER+/HER2- Low Prolif",
                    "Patient's Vital Status": "Living",
                    "Primary Tumor Laterality": "r",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "IDC",
                    "Tumor Size": 65,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }, {
                    "Patient ID": "MB-0593",
                    "Sample ID": "MB-0593",
                    "Nottingham prognostic index": 5.18,
                    "Cancer Type": "Breast Cancer",
                    "Cancer Type Detailed": "Breast Invasive Lobular Carcinoma",
                    "Cellularity": "high",
                    "Chemotherapy": "YES",
                    "Cohort": 1,
                    "ER Status": "-",
                    "ER status measured by IHC": "neg",
                    "HER2 Status": "+",
                    "HER2 status measured by SNP6": "GAIN",
                    "Hormone Therapy": "NO",
                    "Inferred Menopausal State": "post",
                    "Integrative Cluster": "5",
                    "Neoplasm Histologic Grade": 2,
                    "Age at Diagnosis": 62.34,
                    "Oncotree Code": "ILC",
                    "Overall Survival (Months)": 34.66666667,
                    "Overall Survival Status": "DECEASED",
                    "PR Status": "-",
                    "Pam50 + Claudin-low subtype": "Her2",
                    "3-Gene classifier subtype": "HER2+",
                    "Patient's Vital Status": "Died of Disease",
                    "Primary Tumor Laterality": "l",
                    "Radio Therapy": "YES",
                    "Cancer Studies": "brca_metabric",
                    "Sample Type": "Primary",
                    "Tumor Other Histologic Subtype": "ILC",
                    "Tumor Size": 90,
                    "Tumor Stage": 3,
                    "Type of Breast Surgery": "MASTECTOMY"
                }];

                var count = 0;
                var text1 = "";
                text1 += "<div class=\"container\"><table class=\"table table-hover table-striped\"><thead><tr>";
                for (i = 0; i < 1; i++) {
                    for (let key in data[i]) {
                        if (count < 10) {
                            text1 += "<th>" + key + "</th>";
                        }
                        count++;
                    }
                }
                text1 += "</tr></thead><tbody>";

                count = 0;
                for (i = 0; i < data.length; i++) {
                    text1 += "<tr>"
                    for (let key in data[i]) {
                        if (count < 10) {
                            text1 += "<td>" + data[i][key] + "</td>"
                        }
                        count++;
                    }
                    count = 0;
                    //text += "<td>" + data[i].PatientID + "</td>" 
                    text1 += "</tr>"
                }
                text1 += " </tbody></table></div>"


                count = 0;
                var text2 = "";
                text2 += "<div class=\"container\"><table class=\"table table-hover table-striped\"><thead><tr>";
                for (i = 0; i < 1; i++) {
                    for (let key in data[i]) {
                        if (count < 2) {
                            text2 += "<th>" + key + "</th>";
                        }
                        if (count > 9 && count < 18) {
                            text2 += "<th>" + key + "</th>";
                        }
                        count++;
                    }


                }
                text2 += "</tr></thead><tbody>";

                count = 0;
                for (i = 0; i < data.length; i++) {
                    text2 += "<tr>"
                    for (let key in data[i]) {
                        if (count < 2) {
                            text2 += "<td>" + data[i][key] + "</td>";
                        }
                        if (count > 9 && count < 18) {
                            text2 += "<td>" + data[i][key] + "</td>"
                        }
                        count++;
                    }
                    //text += "<td>" + data[i].PatientID + "</td>" 
                    count = 0;
                    text2 += "</tr>"
                }
                text2 += " </tbody></table></div>"


                count = 0;
                var text3 = "";
                text3 += "<div class=\"container\"><table class=\"table table-hover table-striped\"><thead><tr>";
                for (i = 0; i < 1; i++) {
                    for (let key in data[i]) {
                        if (count < 2) {
                            text3 += "<th>" + key + "</th>";
                        }
                        if (count > 19 && count < 28) {
                            text3 += "<th>" + key + "</th>";
                        }
                        count++;
                    }


                }
                text3 += "</tr></thead><tbody>";

                count = 0;
                for (i = 0; i < data.length; i++) {
                    text3 += "<tr>"
                    for (let key in data[i]) {
                        if (count < 2) {
                            text3 += "<td>" + data[i][key] + "</td>";
                        }
                        if (count > 19 && count < 28) {
                            text3 += "<td>" + data[i][key] + "</td>"
                        }
                        count++;
                    }
                    //text += "<td>" + data[i].PatientID + "</td>" 
                    count = 0;
                    text3 += "</tr>"
                }
                text3 += " </tbody></table></div>"

                count = 0;
                var text4 = "";
                text4 += "<div class=\"container\"><table class=\"table table-hover table-striped\"><thead ><tr>";
                for (i = 0; i < 1; i++) {
                    for (let key in data[i]) {
                        if (count < 2) {
                            text4 += "<th style=\"width:16.66% !important\">" + key + "</th>";
                        }
                        if (count > 27 && count < 32) {
                            text4 += "<th style=\"width:16.66% !important\">" + key + "</th>";
                        }
                        count++;
                    }


                }
                text4 += "</tr></thead><tbody>";

                count = 0;
                for (i = 0; i < data.length; i++) {
                    text4 += "<tr>"
                    for (let key in data[i]) {
                        if (count < 2) {
                            text4 += "<td style=\"width:16.66% !important\">" + data[i][key] + "</td>";
                        }
                        if (count > 27 && count < 32) {
                            text4 += "<td style=\"width:16.66% !important\">" + data[i][key] + "</td>"
                        }
                        count++;
                    }
                    //text += "<td>" + data[i].PatientID + "</td>" 
                    count = 0;
                    text4 += "</tr>"
                }
                text4 += " </tbody></table></div>"

                //var text = text1 + text2 + text3 + text4;
                document.getElementById("part1").innerHTML = text1;
                document.getElementById("part2").innerHTML = text2;
                document.getElementById("part3").innerHTML = text3;
                document.getElementById("part4").innerHTML = text4;
            </script>
        </div>
</body>

</html>